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Abstract
Stimulus-dependent elevation of intracellular Ca
2+ ([Ca
2+]i) affects the expression of numerous genes – a phenomenon
known as excitation-transcription coupling. Recently, we found that increases in [Na
+]i trigger c-Fos expression via a novel
Ca
2+
i-independent pathway. In the present study, we identified ubiquitous and tissue-specific [Na
+]i/[K
+]i-sensitive
transcriptomes by comparative analysis of differentially expressed genes in vascular smooth muscle cells from rat aorta
(RVSMC), the human adenocarcinoma cell line HeLa, and human umbilical vein endothelial cells (HUVEC). To augment [Na
+]i
and reduce [K
+]i, cells were treated for 3 hrs with the Na
+,K
+-ATPase inhibitor ouabain or placed for the same time in the K
+-
free medium. Employing Affymetrix-based technology, we detected changes in expression levels of 684, 737 and 1839
transcripts in HeLa, HUVEC and RVSMC, respectively, that were highly correlated between two treatments (p,0.0001;
R
2.0.62). Among these Na
+
i/K
+
i-sensitive genes, 80 transcripts were common for all three types of cells. To establish if
changes in gene expression are dependent on increases in [Ca
2+]i, we performed identical experiments in Ca
2+-free media
supplemented with extracellular and intracellular Ca
2+ chelators. Surprisingly, this procedure elevated rather than decreased
the number of ubiquitous and cell-type specific Na
+
i/K
+
i-sensitive genes. Among the ubiquitous Na
+
i/K
+
i-sensitive genes
whose expression was regulated independently of the presence of Ca
2+ chelators by more than 3-fold, we discovered
several transcription factors (Fos, Jun, Hes1, Nfkbia), interleukin-6, protein phosphatase 1 regulatory subunit, dual specificity
phosphatase (Dusp8), prostaglandin-endoperoxide synthase 2, cyclin L1, whereas expression of metallopeptidase Adamts1,
adrenomedulin, Dups1, Dusp10 and Dusp16 was detected exclusively in Ca
2+-depleted cells. Overall, our findings indicate
that Ca
2+
i-independent mechanisms of excitation-transcription coupling are involved in transcriptomic alterations triggered
by elevation of the [Na
+]i/[K
+]i ratio. There results likely have profound implications for normal and pathological regulation
of mammalian cells, including sustained excitation of neuronal cells, intensive exercise and ischemia-triggered disorders.
Citation: Koltsova SV, Trushina Y, Haloui M, Akimova OA, Tremblay J, et al. (2012) Ubiquitous [Na
+]i/[K
+]i-Sensitive Transcriptome in Mammalian Cells: Evidence
for Ca
2+
i-Independent Excitation-Transcription Coupling. PLoS ONE 7(5): e38032. doi:10.1371/journal.pone.0038032
Editor: Yoshiaki Tsuji, North Carolina State University, United States of America
Received February 27, 2012; Accepted April 29, 2012; Published May 29, 2012
Copyright:  2012 Koltsova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Canadian Institutes of Health Research - http://www.cihr-irsc.gc.ca (MOP-62696 and 81392); Kidney Foundation of Canada - http://www.kidney.ca;
Russian Foundation for Fundamental Research - http://www.rfbr.ru/ (09-04-00646A); the grant of the President of the Russian Federation for young investigators -
http://grants.extech.ru (MK-4641-2011.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sergei.n.orlov@umontreal.ca
Introduction
Gene expression is regulated by diverse stimuli to achieve tissue-
specific functional responses via coordinate synthesis of the cell’s
macromolecular components [1]. Electrochemical gradients of
monovalent cations across the plasma membrane (high intracel-
lular potassium, [K
+]i vs low intracellular sodium, [Na
+]i) are
created by the Na
+,K
+-pump and determine a large variety of
physiologically important processes. These processes include
maintenance of resting and action electrical membrane potentials,
regulation of cell volume, secondary transport of mono- and
divalent ions (such as chloride, calcium and phosphate), and
accumulation of nutrients (glucose, amino acids, nucleotides) and
other relevant molecules [2]. More recent studies demonstrated
that side-by-side with the above-listed ‘‘classic’’ Na
+
i,K
+
i-depen-
dent cellular processes, sustained elevation of the [Na
+]i/[K
+]i
ratio in vascular smooth muscle cells, cardiomyocytes, hepatocytes,
renal epithelial and neuronal cells causes differential expression of
c-Fos and other immediate response genes (IRG), as well as cell
type-specific late response genes, such as tumour growth factor-b,
the a1- and b1-subunits of Na
+,K
+-ATPase, myosin light chain,
skeletal muscle actin, atrial natriuretic factor and mortalin (for
review see [3–5]).
According to the generally accepted paradigm Na
+
i/K
+
i-
sensitive mechanism of excitation-transcription coupling is driven
by changes in intracellular [Ca
2+] and activation of several Ca
2+-
sensitive pathways – a phenomenon termed excitation-transcrip-
tion coupling [6–8]. Indeed, it is well-documented that elevation of
the [Na
+]i/[K
+]i ratio typically leads to increases in [Ca
2+]i via
activation of the Na
+/Ca
2+ exchanger [9] and/or voltage-gated
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38032Ca
2+ channels [10]. It has also been shown that promoters of
numerous genes including c-Fos contain serum response element
(SRE) and Ca
2++cAMP response element (CRE) activated by
[Ca
2+] increments in the cytoplasm and nucleus, respectively [11].
In contrast to the aforementioned mechanistic view, we found
that in vascular smooth muscle cells from the rat aorta (RVSMC)
and the human adenocarcinoma cell line (HeLa) the ouabain-
induced changes in the c-Fos expression were preserved in the
presence of Ca
2+ channel blockers and extra- and intracellular
Ca
2+ chelators [12,13]. These results made us conclude that along
with canonical Ca
2+
i-mediated signaling, sustained elevation of the
[Na
+]i/[K
+]i ratio affects gene transcription via unknown Ca
2+
i-
independent mechanism(s) [4]. In the present study, we deployed
Affymetrix technology to characterize the relative impact of Ca
2+
i-
mediated and -independent signaling on changes in gene
expression triggered by sustained elevation of the [Na
+]i/[K
+]i
ratio. To accomplish this goal, we compared transcriptomes in 3
different cell types treated with 2 distinct Na
+,K
+-ATPase
inhibitors in the absence and presence of Ca
2+ chelators. Our
results strongly indicate that, in mammalian cells, Ca
2+
i-indepen-
dent pathways contribute to ubiquitous and cell type-specific
transcriptomic alterations triggered by elevation of the [Na
+]i/
[K
+]i ratio.
Results
Effect of ouabain and K
+-free medium on the [Na
+]i/[K
+]i
ratio and cell viability
Figure 1 illustrates that 3-hr inhibition of the Na
+,K
+-ATPase
by ouabain in HeLa, human umbilical vein endothelial cells
(HUVEC) and RVSMC increased Na
+
i content from ,50 to 400–
600 nmol/mg protein and decreased K
+
i from 600–800 to
,100 nmol/mg protein. In RVSMC the action of K
+-free
medium on the [Na
+]i/[K
+]i ratio was similar, whereas in
HUVEC and HeLa cells the gain of Na
+
i and the loss of K
+
i
triggered by K
+-free medium were higher compared to ouabain by
,20% by ,50%, respectively. Importantly, in all type of cells
exposed to K
+-free medium, the intracellular content of monova-
lent cations was not significantly affected by the addition of
ouabain (Fig. 1). The control experiments demonstrated that 4 hr
treatment with ouabain or K
+-free medium as well as the addition
of 50 mM EGTA and 10 mM BATPA-AM in Ca
2+-free medium
did not impact HeLa, HUVEC and RVSMC survival, as
determined by lactate dehydrogenase (LDH) release, caspase-3
activity and chromatin cleavage assay (Table 1).
Effects of ouabain and K
+-free medium on gene
expression profile
Together with elevation of the [Na
+]i/[K
+]i ratio, ouabain and
K
+-free medium may affect cells independently of suppression of
Na
+,K
+-ATPase-mediated ion fluxes. Thus, recent studies have
revealed that ouabain triggered interaction of the Na
+,K
+-ATPase
a-subunit with the membrane-associated nonreceptor tyrosine
kinase Src, activation of Ras/Raf/ERK1,2, phosphatidyl inositol
3-kinase (PI(3)K), PI(3)K-dependent protein kinase B, phospholi-
pase C, [Ca
2+]i oscillations and augmented production of the
reactive oxygen species (for review, see [14,15]). On the other
hand, the transfer of highly K
+-permeable cells to K
+-free medium
results in transient membrane hyperpolarization, affecting the
activity of diverse voltage-sensitive membrane-bound proteins
[16,17]. Considering this, we compared the actions of ouabain and
K
+-free medium on gene expression profiles in HUVEC, RVSMC
and HeLa cells with a final goal of identifying ubiquitous and cell
type-specific Na
+
i,K
+
i-sensitive transcriptomes.
The data obtained in 4 independent experiments were
normalized and then analyzed by principal component analysis
(PCA) [18]. Each point on the PCA represents the gene expression
profile of an individual sample. Samples that are near each other
in the resulting 3-dimensional plot have a similar transcriptome
while those that are further apart have dissimilar transcriptional
profiles. This approach identified treatments with ouabain and
K
+-free medium as major sources of variability within datasets
(Fig. 2A).
Figure 2B disclosed that the total numbers of differentially-
expressed transcripts in HeLa, HUVEC and RVSMC treated for
3 hr with ouabain were 819, 886 and 3199, whereas inhibition of
the Na
+,K
+-ATPase in K
+-free medium altered the expression of
3078, 2858 and 3677 transcripts, respectively. In all types of cells,
the number of up- and down regulated genes affected by these
stimuli was about the same, whereas maximal fold of activation
and suppression was 65 and 24, respectively (Table 2). The
decreased number of differentially expressed transcripts detected
in ouabain-treated HUVEC and HeLa cells, compared to
RVSMC, can be explained by retarded kinetics of elevation of
[Na
+]i in ouabain-treated human cells compared to ouabain-
treated RVSMC (Fig. 3A) and cells subjected to Na
+,K
+-ATPase
inhibition in K
+-free medium (Fig. 3B). This observation is
consistent with the slow kinetics of ouabain interaction with the
human house-keeping a1N a
+,K
+-ATPase isoform demonstrated
in early investigations [19].
Further analysis determined that the expression of 684, 737 and
1839 transcripts in HeLa, HUVEC and RVSMC, respectively,
was affected by both stimuli (Fig. 2B). Importantly, we observed
highly significant (p,0.0003) and positive (R
2.0.62) correlations
between levels of differentially expressed transcripts identified in
the presence of ouabain and K
+-free medium (Fig. 4). Because the
gain of Na
+
i and loss of K
+
i in cells treated with ouabain and K
+-
free medium are similar (Fig. 1), the results strongly suggest that
the changes in gene expression evoked by both stimuli occur in
response to elevation of the [Na
+]i/[K
+]i ratio rather than due to
Na
+
i,K
+
i-independent events. Considering this, we classified
Na
+
i,K
+
i-sensitive transcriptomes as sets of genes whose expression
was impacted by both ouabain and K
+-free medium.
To confirm the ability of microarrays to resolve the differences
in expression levels, we selected several Na
+
i/K
+
i-sensitive genes
(Egr1, Ptgs2 and Ppp1r15a) for additional validation by quantitative
reverse transcription polymerase chain reaction (qRT-PCR)
analysis. These experiments revealed highly significant correla-
tions between the RT-PCR results and the validated microarray
data (R
2=0.94, p,0.0000002; Fig. 5).
Ubiquitous Na
+
i,K
+
i-sensitive transcriptome
Among the Na
+
i,K
+
i-sensitive genes detected in HeLa, HUVEC
and RVSMC, we identified 80 common genes, i.e. genes whose
differential expression was increased or decreased by both ouabain
and K
+-free medium by at least 1.2-fold (p,0.05) in all 3 cell types
(Fig. 6A). We noted that the list of ubiquitous Na
+
i,K
+
i-sensitive
transcriptome was enriched with genes involved in the regulation
of transcription/translation (49%), cell cycle, adhesion and
migration (24%), and inflammatory and immune responses (6%)
(Table 3, Fig. 6B).
Ubiquitous Na
+
i/K
+
i-sensitive genes, whose expression was
increased by more than 3-fold, included the transcriptional
regulator of C2H2-type zinc-finger protein Egr-1, members of
the superfamily of b-zip transcriptional factors possessing basic
DNA-binding domain and leucine-zipper dimerization motif and
forming heterodimeric activating protein-1 (AP-1) (Fos, FosB, Jun,
JunB, Atf3), transcription factor of the steroid-thyroid hormone-
Intracellular Ions and Gene Expression
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transcription regulator Hes1. Nfkbiz and Nfkbia are transcriptional
regulators of genes encoding intermediates of inflammation
whereas interleukin 6 (Il6) is a potent controller of the acute
inflammatory response phase. Prostaglandin-endoperoxide syn-
thase 2 (Ptgs2) also known as cyclooxygenase-2 is a key enzyme in
the biosynthesis of prostaglandins implicated in inflammatory
responses and mitogenesis. Na
+
i/K
+
i-sensitive regulators of cell
Figure 1. Effect of ouabain and K
+-free medium on intracellular Na
+ (a–c) and K
+ (d–f) content in HeLa (a,d), HUVEC (b,e) and RVSMC
(c,f). Cells were incubated in control or K
+-free medium during 3 hr and ouabain was added at a final concentration of 3 mM (HeLa and HUVEC) or
3 mM (RVSMC). Mean 6 S.E. values of experiments performed in quadruplicate are shown.
doi:10.1371/journal.pone.0038032.g001
Table 1. Lactate dehydrogenase release (LDH, %), caspase-3 activity (CAS, nmol per mg of protein per hr) and chromatin cleavage
(CHR, %) in cells treated with ouabain, K
+-free and Ca
2+-free medium during 4 hr.
Incubation medium,
additions HeLa HUVEC RVSMC
LDH CAS CHR LDH CAS CHR LDH CAS CHR
None (control) 5.361.6 0.3660.05 3.360.9 7.062.1 0.2660.07 4.460.7 3.060.6 0.4660.04 5.161.2
Ouabain 6.360.6 0.4460.07 2.961.6 7.361.6 0.4160.08 6.961.8 4.361.1 0.3760.03 3.962.6
K
+-free medium 5.961.1 0.3060.05 4.061.0 5.961.7 0.3660.04 4.761.3 4.560.6 0.3860.05 4.861.0
Ca
2+-fre medium 6.961.2 0.4660.09 4.961.6 8.563.0 0.5360.07 7.161.7 5.561.1 0.5760.08 6.962.2
Staurosporine 15.162.6* 1.3360.25* 19.164.4* 35.363.9* 1.7860.18* 32.166.4* 21.362.2* 2.9160.30* 23.165.0*
To measure LDH release and chromatin cleavage, the total content of LDH and [
3H]-labelled DNA were taken as 100%. Ouabain was added at final concentration of
3 mM (HeLa and HUVEC) or 3 mM (RVSMC). Ca
2+-free medium contained 50 mM EGTA and 10 mM BAPTA-AM. Staurosporine, a potent trigger of apoptosis, was added as
a positive control at concentration of 1 mM. Means 6 S.E. from experiments performed with quadruplicate are given.
*p,0.05 as compared to controls.
doi:10.1371/journal.pone.0038032.t001
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increased are represented by dual specificity protein phosphatase
Dusp8, inhibitor of the receptor-transduced mitogen-activated
protein kinase signaling pathway Spry4, the protein phosphatase 1
regulatory subunit Ppp1r15a, the cytokine inducible kinase Plk3,a
member of the epidermal growth factor (EGF) family amphir-
egulin (Areg), and heparin-binding EGF-like growth factor Hbegf.
Among ubiquitous Na
+
i,K
+
i-sensitive genes from other func-
tional categories, we noted augmented expression of oxidative
stress mediator Txnip, the low-density lipoprotein receptor Ldlr, the
regulator of cholesterol synthesis Insig1 and 2 carriers involved in
intracellular phosphate handling, i.e. the Ca
2+-dependent mito-
chondrial solute carrier Slc25a25 mediating ATP-Mg/Pi exchange
and the sodium-phosphate symporter Slc20a1 (Table 3). In
contrast to substantial number of ubiquitous Na
+
i/K
+
i-sensitive
genes that were strongly up-regulated, we identified only one
transcript – the epsilon subunit of GABA-activated Cl
2 channel
(Gabre) – whose expression was decreased by more than 3-fold
(Table 3).
Cell type-specific Na
+
i,K
+
i-sensitive transcriptomes
Because the number of cell-type specific Na
+
i,K
+
i-sensitive
transcripts is very large (Fig. 2B, Table 2), we restricted their
functional characterization to genes whose expression was altered
by more than 4-fold. The relevant analysis led us to several
conclusions. First, ubiquitous genes comprised up to ,50% of
Na
+
i,K
+
i-sensitive genes whose expression was increased in HeLa,
HUVEC and RVSMC by more than 4-fold (Tables 4,5,6). Second,
strongly up-regulated Na
+
i,K
+
i-sensitive genes are abundant with
the transcripts that were detected in 2 cell types. These transcripts
(underlined and bold) accounted for 37%, 18% and 16% of the
total numbers of genes that manifested up- and down-regulation in
Figure 2. Comparative analysis of the actions of Na
+,K
+-ATPase inhibition by ouabain and K
+-free medium on HeLa, HUVEC and
RVSMC transcriptomes. A. Principal component analysis of the transcriptomes of HeLa, HUVEC and RVSMC. Cells were incubated for 3 hr in
control Ca
2+-containing media and processed for oligonucleotide microarray analysis as indicated in the Methods section. Ouabain was added at a
final concentration of 3 mM (HeLa and HUVEC) or 3 mM (RVSMC). All experiments are repeated 4 times. Ellipsoids highlight portioning of samples
based on the type of treatment. The principal components in 3-dimensional graphs (PC#1, PC#2 and PC#3) represent the variability of gene
expression level within datasets. The total percentage of PCA mapping variability is shown on top. B. The total number of genes whose expression is
altered by ouabain and K
+-free medium by more than 1.2-fold with p,0.05 is indicated; numbers of genes affected by both stimuli appear in bold.
doi:10.1371/journal.pone.0038032.g002
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ubiquitously regulated genes (Table 3), the list of cell type-specific
Na
+
i,K
+
i-sensitive genes that were strongly up- and down-
regulated was enriched with the transcriptional regulators and
regulators of immune responses and inflammation. Examples
included nuclear receptor subfamily 4 group A Nr4a1 and Nr4a3 in
HeLa and RVSMC, early growth response 2 Egr2 in HeLa and
RVSMC, immediate early response 2 Ier2 in RVSMC, interleukin
Figure 3. Kinetics of elevation of intracellular Na
+ in HeLa, HUVEC and RVSMC triggered by ouabain (A) or K
+-free medium (B).
Ouabain was added at a final concentration of 3 mM (HeLa and HUVEC) or 3 mM (RVSMC). Intracellular Na
+ content in the absence of Na
+,K
+-ATPase
inhibitors was taken as 100%. Means obtained in experiments performed in triplicate are shown.
doi:10.1371/journal.pone.0038032.g003
Table 2. Total numbers of differentially expressed transcripts in HeLa, HUVEC and RVSMC in 3-hr of Na
+,K
+-ATPase inhibition in
control (Ca
2+ containing) medium.
Ouabain-treated cells Cells treated with K
+-free medium
Transcripts affected by both
stimuli
HeLa
Up-regulated transcripts
Number of transcripts 338 1371 278
Maximal fold of activation 13.78 46.86 N.A.
Down-regulated transcripts
Number of transcripts* 481 1707 406
Maximal fold of inhibition 2.85 7.96 N.A.
HUVEC
Up-regulated transcripts
Number of transcripts 400 1471 355
Maximal fold of activation 9.68 64.81 N.A.
Down-regulated transcripts
Number of transcripts* 486 1447 379
Maximal fold of inhibition 2.40 5.33 N.A.
RVSMC
Up-regulated transcripts
Number of transcripts 1288 1872 894
Maximal fold of activation 9.46 24.32 N.A.
Down-regulated transcripts
Number of transcripts* 1903 1805 945
Maximal fold of inhibition 4.15 7.50 N.A.
Transcripts whose expression was altered by more than 1.2-fold with p,0.05 were subjected to analysis. Ouabain was added at final concentration of 3 mM (HeLa and
HUVEC) or 3 mM (RVSMC). N.A. – non-applicable.
doi:10.1371/journal.pone.0038032.t002
Intracellular Ions and Gene Expression
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e380328 IL8 in HeLa and HUVEC, tumour necrosis factor a-induced
protein 3 TNFAIP3 in HeLa and HUVEC. From other functional
categories, we observed substantial cell type-specific elevation of
colony stimulating factor 3 Csf3 in RVSMC, metallopeptidase
ADAMTS1 and vasoactive intestinal peptide VIP in HUVEC, the
regulator of G-protein signalling Rgs2 in RVSMC, endothelin 1
EDN1 and the inhibitor of DNA binding-2 ID2 in HeLa cells
(Tables 4,5,6).
Effects of Ca
2+-free medium and intracellular Ca
2+
chelation on gene expression
To trigger Ca
2+-depletion, we incubated cells in Ca
2+-free
medium containing extra- and intracellular Ca
2+ chelators (50 mM
EGTA and 10 mM BAPTA-AM, respectively). Figure 7A displays
that in HeLa cells this procedure almost completely abolished
sharp elevation of [Ca
2+]i evoked by activation of purinergic
receptors by ATP. We did not reveal any significant elevation of
[Ca
2+]i in Ca
2+-depleted, ATP-treated HUVEC and RVSMC
(Fig. 7B).
Similarly to the results obtained in Ca
2+-containing media, PCA
found that treatments with ouabain and K
+-free medium
produced dramatic changes in gene expression in Ca
2+-depleted
HUVEC, RVSMC and HeLa cells (Fig. 8A). Figures 8B and
Table 7 show that in all types of Ca
2+-depleted cells, the numbers
of differentially expressed genes were increased in comparison to
cells incubated in Ca
2+-containing media (Fig. 3B, Table 2). As in
Ca
2+-containing media, we ascertained significant positive corre-
lations between the differential expression of transcripts triggered
by ouabain and K
+-free medium in Ca
2+-depleted RVSMC
(R
2=0.98; p,0.03), HUVEC (R
2=0.96; p,3610
27) and HeLa
cells (R
2=0.93; p,2610
220) (Fig. 9). Importantly, the number of
Na
+
i,K
+
i-sensitive transcripts, i.e. transcripts whose expression is
affected by both ouabain and K
+-free medium, was also increased
in the presence of extra- and intracellular Ca
2+ chelators by ,3
fold in HeLa and HUVEC and by 2-fold in RVSMC (Fig. 10A,
compare to Fig. 6A).
Further analysis disclosed that (i) less than 25% of ubiquitous
Na
+
i,K
+
i-sensitive genes were detected in the Ca
2+-containing
Figure 4. Correlation analysis of transcripts whose expression is altered by ouabain and K
+-free medium in HeLa, HUVEC and
RVSMC by more than by 1.2-fold with p,0.05. Cells were incubated during 3 hr; ouabain was added at a final concentration of 3 mM (HeLa and
HUVEC) or 3 mM (RVSMC). Incubation medium contains 1.8 mM CaCl2. The total number of transcripts subjected to analysis is shown in Figure 2B.
Transcript expression in control cells was taken as 1.00.
doi:10.1371/journal.pone.0038032.g004
Figure 5. Verification of microarray results by quantitative RT-PCR. Gene expression was quantified for 3 hr incubation of control and Ca
2+-
depleted HUVEC in the presence of 3 mM ouabain or in K
+-free medium. Mean values obtained in 4 independent experiments are shown. Egr1 - early
growth response protein 1, Ptgs2 - prostaglandin-endoperoxide synthase 2, Ppp1r15a - protein phosphatase 1, regulatory (inhibitor) subunit 15A.
doi:10.1371/journal.pone.0038032.g005
Intracellular Ions and Gene Expression
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+
i,K
+
i-
sensitive genes was independent on the presence of extra- and
intracellular Ca
2+ chelators, and (iii) more than 60% of ubiquitous
and cell type-specific Na
+
i,K
+
i-sensitive genes were found exclu-
sively in Ca
2+-depleted cells (Fig. 11). In HeLa cells, among the
Na
+
i,K
+
i-sensitive genes whose expression was changed by
ouabain or K
+-free medium by more than 4-fold, we did not
observe any genes whose differential expression was abolished by
Ca
2+ depletion (Table 4). In HUVEC and RVSMC this procedure
eliminated differential expression of ,3 and 20% of transcripts,
respectively (Tables 5,6).
To further verify the efficacy of Ca
2+ depletion procedure
employed in our study, we compared intracellular concentration of
BAPTA, Ca
2+
i and expression of 3 selected genes in HeLa cells
incubated in the presence of 10 or 100 mM BAPTA-AM. In
control Ca
2+-containing medium, 3 hr incubation of HeLa cells
with ouabain elevated [Ca
2+]i by ,35% and increased content of
EGR1, PTGS2 and PPP1R15A RNAs by ,56-, 6- and 9-fold,
respectively (Table 8). Addition of 10 mM BAPTA-AM in Ca
2+-
free medium containing 50 mM EGTA completely abolished an
increment of [Ca
2+]i triggered by ouabain and increased the
content of EGR1, PTGS2 and PPP1R15A RNAs by ,6-, 2- and
1.3-fold, respectively. Elevation of BATPA-AM concentration in
the incubation medium up to 100 mM increased intracellular
[BAPTA] from 127 to 735 mM and augmented expression of
EGR1, PTGS2 and PPP1R15A by ,9-, 2,5- and 2.2-fold,
respectively. This action of Ca
2+-depletion procedure is probably
caused by elevation of the passive permeability of the plasma
membrane for Na
+ and [Na
+]i/[K
+]i ratio detected in EGTA- and
BAPTA-AM-treated RVSMC [20]. Importantly, elevation of
intracellular [BAPTA] up to 735 mM did not abolished increments
of gene expression evoked by 3 hr incubation with ouabain
(Table 8).
Table 9 lists the ubiquitous Na
+
i,K
+
i-sensitive genes, which were
detected in Ca
2+-depleted RVSMC, HUVEC and HeLa cells.
Similarly to Ca
2+-containing conditions, ubiquitous Na
+
i,K
+
i-
sensitive transcriptomes in the Ca
2+-depleted cells were abundant
with regulators of transcription/translation, cell cycle control and
inflammatory/immune responses (Fig. 10B). Importantly, the
actions of elevated [Na
+]i/[K
+]i ratio on the differential expression
of several genes shown in Table 8 in italics, such as nuclear
receptor Nr4a1, anti-proliferative gene Btg2, angiogenic inducer
Cyr61, adrenomedulin Adm and regulator of G-protein signaling
Rgs2, were abolished in the presence of Ca
2+. We also noted that in
Ca
2+-depleted cells 23 genes or 13% of ubiquitous Na
+
i,K
+
i-
sensitive transcriptome were involved in protein folding and
ubiquitination. This is in contrast to 2 genes in the same functional
category that were detected in the presence of Ca
2+ (Fig. 6B).
These results are consistent with numerous observations that Ca
2+-
depletion causes endoplasmic reticulum stress and activates
unfolded protein response (for review, see [21]).
Based on this work we selected 8 ubiquitous Na
+
i,K
+
i-sensitive
genes whose expression was increased by more than 5-fold in
Ca
2+-containing media, and whose augmented expression was
preserved in the presence of extra- and intracellular Ca
2+
chelators. As seen in Figure 12, Ca
2+-depletion strongly attenuated
(but did not completely abolish) Na
+
i/K
+
i-dependent changes in
gene expression for FosB, Il6, Pppr1r15a and Ptgs2 in all cell types.
In contrast, Ca
2+-depletion slightly decreased, did not affect, or
increased expression of Fos, Zfp36, Jun and Dusp8 in a cell type-
specific manner. These results further illustrate that (i) [Ca
2+]i
elevation is not obligatory for changes in gene expression, and (ii)
Ca
2+
i-dependent signaling may have complex effects on ubiquitous
and cell type specific Na
+
i,K
+
i-sensitive transcriptomes.
Discussion
In the present study we utilized genome-wide Affymetrix arrays
to identify [Na
+]i/[K
+]i-sensitive transcriptomes in 3 diverse cell
lines. Based on the results presented here we can conclude that
elevation of the [Na
+]i/[K
+]i-ratio causes robust changes in gene
expression in both ubiquitous and cell type-dependent manners.
The number of regulated transcripts was high and represented
more than 2% of the total genome. Surprisingly, Ca
2+-depletion
increased rather than decreased number of the [Na
+]i/[K
+]i-
Figure 6. Na
+
i,K
+
i-sensitive transcriptomes identified in control Ca
2+-containing media. A. Pie-chart showing the numbers of Na
+
i,K
+
i-
sensitive genes detected in HeLa, HUVEC and RVSMC and ubiquitous Na
+
i,K
+
i-sensitive genes found in all 3 cell types. B. Distribution of ubiquitous
Na
+
i,K
+
i-sensitive genes among major functional groups. Digitals shown in italics correspond to gene numbers for each functional group.
doi:10.1371/journal.pone.0038032.g006
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+
i/K
+
i-sensitive genes whose expression was up- and down-regulated by more than 1.2-fold (p#0.05) in
control (Ca
2+-containing) medium.
No. Gene symbol, title RVSMC HUVEC HeLa
Fold of activation/
inhibition
Fold of activation/
inhibition
Fold of activation/
inhibition
ouabain
K
+-free
medium ouabain
K
+-free
medium ouabain
K
+-free
medium
Up-regulated genes
1t Egr1//early growth response 1 4.8060.18 6.9760.18 9.6960.15 64.8160.12 13.7860.15 46.8560.09
2t Fos//FBJ osteosarcoma oncogene 3.1760.08 8.7660.08 2.6060.09 15.9760.11 5.8860.13 41.9360.09
3t Fosb//FBJ osteosarcoma oncogene B 5.9160.11 15.2260.12 1.9960.08 5.8260.10 3.1260.16 23.8560.11
4t Atf3//activating transcription factor 3 4.7260.03 20.6360.08 1.8660.05 7.5060.05 2.2860.10 11.2960.05
5t Zfp36//zinc finger protein 36 3.5260.10 5.9560.09 2.3660.10 12.0760.11 2.2760.04 10.3060.10
6t Jun//Jun oncogene 1.2860.06 1.6260.07 1.9460.06 5.1160.05 1.9160.11 8.0360.04
7i Il6//interleukin 6 3.4060.14 4.7660.15 1.4460.09 2.1260.08 2.0160.11 8.0160.08
8d Ppp1r15a//protein phosphatase 1, regulatory
(inhibitor) subunit 1
2.5960.12 3.5760.09 2.5460.10 4.0860.10 2.9860.16 7.7360.14
9d Dusp8//dual specificity phosphatase 8 1.5560.11 3.0960.12 1.5460.08 3.3560.06 1.8360.11 6.2560.10
10t Ddit3//DNA-damage inducible transcript 3 2.1560.03 4.2660.03 1.3560.09 4.9160.09 1.5260.13 5.4660.10
11t Junb//jun B proto-oncogene 4.0360.08 4.2460.07 1.8560.09 7.3260.07 2.2060.09 5.4060.08
12i Ptgs2//prostaglandin-endoperoxide synthase 2 9.4660.10 9.9560.11 3.7360.03 7.8460.04 2.3960.13 5.1560.10
13t Cyr61//cysteine-rich, angiogenic inducer, 61 1.7160.09 2.0060.10 1.3460.04 2.1160.04 2.0260.09 5.1160.08
14t Nr4a2//nuclear receptor subfamily 4, group A,
member 2
5.1960.07 8.6560.12 2.0360.09 3.9460.10 2.3960.07 4.7660.05
15i Nfkbiz//nuclear factor of kappa light polypeptide
gene enhance
3.2460.09 4.4760.08 2.4460.06 5.1560.02 2.1160.07 4.6660.07
16t Hes1//hairy and enhancer of split 1 (Drosophila) 3.0060.06 6.1560.09 2.0760.09 5.8660.08 1.7160.10 4.6260.11
17d Spry4//sprouty homolog 4 (Drosophila) 1.8460.06 1.4060.09 3.2760.12 4.9160.12 2.1260.17 4.2660.17
18o Txnip//thioredoxin interacting protein 3.8560.10 5.8460.10 2.6260.09 6.9960.12 3.0760.10 4.1860.09
19d Areg//amphiregulin 1.9060.04 1.7560.06 1.3660.11 1.3960.07 1.9360.13 4.1360.14
20i Nfkbia//nuclear factor of kappa light
polypeptide gene
2.4660.03 5.8060.05 1.3960.09 2.6860.08 1.5460.10 3.6360.10
21t Klf10//Kruppel-like factor 10 2.8060.05 3.6660.06 1.8360.07 4.5360.05 1.7460.06 3.5760.05
22d Plk3//polo-like kinase 3 (Drosophila) 3.2960.12 3.6460.12 1.2260.06 2.1560.06 1.4160.05 2.8360.07
23d Ccnl1//cyclin L1 2.1060.06 3.8260.08 1.6260.05 2.7360.04 1.3360.09 2.7260.08
24d Abl2//v-abl Abelson murine leukemia viral
oncogene homolog 2
1.9660.11 2.0260.08 1.4460.06 2.0460.05 1.7460.07 2.6260.05
25d Pmaip1//phorbol-12-myristate-13-acetate-induced
protein 1
1.4660.06 1.6460.05 1.5160.11 2.3060.11 1.7160.08 2.5560.06
26t Bcl6//B-cell CLL/lymphoma 6 1.6460.10 1.8860.09 1.8960.07 3.7860.07 1.3260.10 2.5360.10
27t Mafk//v-maf musculoaponeurotic fibrosarcoma
oncogene homolog K
2.9460.08 3.1960.11 1.3760.08 1.2360.08 1.5960.07 2.5060.07
28d Errfi1//ERBB receptor feedback inhibitor 1 3.1460.07 2.5960.10 1.7560.07 3.0660.07 1.4560.05 2.4260.06
29o Dusp16//dual specificity phosphatase 16 2.3360.08 2.4760.09 1.6260.09 3.4960.08 1.4660.11 2.3860.11
30t Maff//v-maf musculoaponeurotic fibrosarcoma
oncogene homolog F
2.4760.07 3.1160.09 1.2760.09 2.2560.04 1.4260.10 2.3560.10
31t Tsc22d2//TSC22 domain family, member 2 1.2160.04 1.7660.06 1.8060.05 3.8060.03 1.4160.05 2.2460.05
32o Slc25a25//solute carrier family 25 2.1860.03 3.5660.05 1.7760.06 2.9760.05 1.4960.05 2.2360.07
33o Insig1//insulin induced gene 1 1.9360.08 1.9660.09 1.3660.04 1.8660.03 1.6760.06 2.2360.05
34t Mxd1//max dimerization protein 1 1.8360.06 3.2160.05 1.4960.07 2.4260.06 1.6660.08 2.1960.08
35t Fosl1//fos-like antigen 1 1.9260.07 2.1760.07 1.2960.04 2.3560.04 1.2060.04 2.1760.06
36d Hbegf//heparin-binding EGF-like growth factor 4.4460.14 4.1060.18 1.5260.06 2.2560.03 1.3560.07 2.1360.08
37d Epha2//Eph receptor A2 3.6160.08 2.9860.12 1.3160.07 1.4160.06 1.3960.11 2.1160.08
38d Birc3//baculoviral IAP repeat-containing 3 3.3060.03 7.4760.03 1.6960.09 4.5860.12 1.29/60.09 2.0460.09
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No. Gene symbol, title RVSMC HUVEC HeLa
Fold of activation/
inhibition
Fold of activation/
inhibition
Fold of activation/
inhibition
ouabain
K
+-free
medium ouabain
K
+-free
medium ouabain
K
+-free
medium
39d Efna1//ephrin A1 1.8260.04 1.2660.03 1.4860.04 1.8360.05 1.3460.09 2.0260.09
40t Zc3h12c//zinc finger CCCH type containing 12C 1.3960.06 1.7060.02 1.7660.09 1.6260.09 1.6860.08 2.0160.07
41o Ldlr//low density lipoprotein receptor 1.5060.04 1.5160.04 1.4860.05 1.8660.05 1.7560.03 1.9560.04
42t Sertad2//SERTA domain containing 2 1.7460.06 1.6060.07 1.3660.08 1.7960.07 1.2960.09 1.9360.07
43t Zc3h12a//zinc finger CCCH type containing 12A 2.1460.06 2.2560.08 1.3560.06 2.6860.07 1.2560.05 1.9260.03
44t Cpeb4//cytoplasmic polyadenylation element
binding protein 4
2.4660.04 2.5960.05 1.2660.06 1.7460.07 1.3160.06 1.8760.05
45i Il1rap//interleukin 1 receptor accessory protein 1.3260.09 1.2160.06 1.3360.10 1.9960.10 1.4260.09 1.7160.07
46f Dnajb9//DnaJ (Hsp40) homolog, subfamily B,
member 9
1.3360.03 1.3060.03 1.6360.05 2.2060.06 1.4660.07 1.6760.10
47t Ppp1r15b//protein phosphatase 1 1.7260.02 1.7760.02 1.3060.05 1.6360.03 1.3560.04 1.6660.03
48d Dusp6//dual specificity phosphatase 6 3.3660.10 1.7360.11 1.4760.12 1.8160.09 1.4860.07 1.6460.07
49d Zswim6//zinc finger, SWIM-type containing 6 1.4460.03 1.7060.04 1.2260.03 1.6460.03 1.3560.02 1.6260.03
50t Zbtb43//zinc finger and BTB domain containing 43 1.3460.05 2.1460.05 1.2460.06 1.7660.08 1.3960.05 1.5960.05
51o Slc20a1//solute carrier family 20 (phosphate
transporter)
1.5660.04 1.2960.04 1.3060.03 1.4360.04 1.2960.04 1.5660.04
52o Hmgcs1//3-hydroxy-3-methylglutaryl-Coenzyme A
synthase 1
1.8060.03 2.0160.03 1.2460.02 1.5660.01 1.3860.04 1.4460.03
53f Coq10b//coenzyme Q10 homolog B (S. cerevisiae) 1.7160.03 1.4760.03 1.2260.04 1.4760.05 1.4160.05 1.4360.06
54t Clk1//CDC-like kinase 1 1.3760.07 2.1460.07 1.4060.07 1.6660.07 1.4160.06 1.4060.07
55t Zbtb11//zinc finger and BTB domain containing 11 2.1660.05 2.0060.08 1.4260.05 1.5160.05 1.3160.04 1.3660.05
56t Nr1d1//nuclear receptor subfamily 1, group D,
member 1
1.5760.05 1.7460.08 1.4360.10 1.4860.07 1.5060.07 1.3160.09
57o Stard4//StAR-related lipid transfer (START) domain 1.3060.05 1.5160.05 1.3260.06 1.4660.03 1.3960.07 1.3060.05
58t Nfya//nuclear transcription factor-Y alpha 1.5260.06 1.4560.09 1.4960.04 1.4860.04 1.4160.05 1.3060.04
59t Jmjd1c//jumonji domain containing 1C 1.4960.03 1.5960.05 1.3960.03 1.5260.05 1.2860.04 1.2960.05
60t Dcp1a//DCP1 decapping enzyme homolog A (S.
cerevisiae)
1.6660.02 1.6560.06 1.2460.03 1.2660.03 1.2760.06 1.2860.04
61t E2f3//E2F transcription factor 3 1.2660.06 1.4360.05 1.4160.08 1.7360.08 1.2260.06 1.2760.04
Down-regulated genes
1o Gabre//gamma-aminobutyric acid (GABA) A
receptor, epsilon
21.2160.08 21.4560.06 21.3360.06 21.4860.03 22.0160.09 23.1560.14
2t Hoxb5//homeo box B5 22.2560.12 22.8260.13 21.7560.06 23.0060.08 21.4960.08 22.3560.09
3t Znf250//zinc finger protein 250 21.2660.07 21.2060.08 21.6260.06 21.9060.05 21.7260.07 22.0860.06
4t Rpp40//ribonuclease P 40 subunit (human) 21.7060.08 21.8460.05 21.4160.03 21.7960.06 21.2760.05 22.0360.06
5t Rbm45//RNA binding motif protein 45 21.3360.05 21.3760.05 21.4160.06 21.6760.05 21.4860.11 21.8960.08
6d Aggf1//angiogenic factor with G patch and FHA
domains 1
21.5460.04 21.2460.06 21.3060.08 21.2960.08 21.5460.07 21.8360.06
7d Fancf//Fanconi anemia, complementation group F 21.5160.07 21.3060.06 21.8560.08 21.7160.07 21.4860.10 21.8360.09
8o Rhobtb1//Rho-related BTB domain containing 1 21.9860.06 21.3560.06 21.4160.08 21.4860.08 21.3460.11 21.8060.07
9t Znf691//zinc finger protein 691 21.4260.09 21.3360.07 21.2860.08 21.2360.07 21.4660.11 21.6760.06
10o Rrs1//RRS1 ribosome biogenesis regulator
homolog (S. cerevisiae)
21.2660.07 21.3960.10 21.3160.08 21.3360.07 21.2960.03 21.5960.03
11t Mrpl46//mitochondrial ribosomal protein L46 21.3460.04 21.2460.05 21.2160.04 21.3460.03 21.2460.05 21.5860.07
12o Golga5//golgi autoantigen, golgin subfamily a 21.6560.04 21.2160.06 21.3860.05 21.4860.05 21.2960.05 21.5660.04
13d Psrc1//proline/serine-rich coiled-coil 1 21.6560.08 21.8060.07 21.2560.08 21.4460.05 21.2360.04 21.5360.05
14o Spata7//spermatogenesis associated 7/ 21.5560.07 21.3260.06 21.2960.06 21.3160.06 21.3860.08 21.4960.08
15d Tgfbrap1//transforming growth factor, beta receptor 21.4960.06 21.2260.05 21.3660.05 21.5560.03 21.2960.06 21.4760.05
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unidentified Ca
2+
i-independent mechanisms of transcriptional
regulation, which are determined by the intracellular concentra-
tion of monovalent cations.
Characterization of ubiquitous Na
+
i,K
+
i-sensitive
transcriptome
We observed that sustained Na
+,K
+-ATPase inhibition by
ouabain led to the differential expression of 886 transcripts in
primary cultured human endothelial cells, 819 transcripts in
human epitheloid carcinoma cell line and 3191 transcripts in
smooth muscle cells obtained from the rat aorta (Fig. 2).
Differentially regulated genes represent ,3 and ,10% of genes
in human and rat genome, respectively. Keeping in mind that
ouabain may affect signaling pathways independently of inhibition
of Na
+,K
+-ATPase [14,15], we tested K
+-free medium as an
alternative approach to elevation of the [Na
+]i/[K
+]i ratio. Three
hour incubation of cells in K
+-free medium resulted in gain of Na
+
i
and loss of K
+
i that were quantitatively similar to those triggered
by ouabain (Fig. 1). We found highly significant positive
correlations between the levels of transcripts impacted by both
stimuli (Fig. 4). These data strongly indicate that differential gene
expression is evoked by elevation of the [Na
+]i/[K
+]i ratio rather
than by Na
+
i,K
+
i-independent mechanisms.
Among 684, 737 and 1839 Na
+
i,K
+
i-sensitive transcripts
detected in HeLa, HUVEC and RVSMC, we discerned 80 genes
whose expression was increased up to 60-fold or decreased up to
,3-fold independently of the origin of cultured cells (Table 3). It
should be noted that because of the retarded kinetics of elevation
of the [Na
+]i/[K
+]i ratio in human cells (Fig. 3), the number of
Na
+
i,K
+
i-sensitive genes in HeLa and HUVEC as well as the
number of ubiquitous Na
+
i,K
+
i-sensitive genes is probably
underestimated.
Functional analysis demonstrated that almost the half of the
ubiquitous Na
+
i,K
+
i-sensitive genes belonged to transcription and
translation regulators (Fig. 6). Important examples include Egr1,
Fos, Fosb, Atf3, Jun, Ddit3, Junb, Cyr61. Although functional
characterization is somewhat artificial – because genes are usually
multifunctional and fall into several categories – the relative
content of transcriptional regulators identified in the ubiquitous
Na
+
i,K
+
i-sensitive transcriptome was ,7-fold higher than in total
human genome [22]. These findings strongly suggest that
heightened expression of ubiquitous Na
+
i,K
+
i-sensitive regulators
of transcription underlie ubiquitous and cell-type specific tran-
scriptomic modifications triggered by elevation of the [Na
+]i/
[K
+]i. This conclusion is supported by analysis of the top gene
expression network revealed using the IPA Knowledge Base
software. Indeed, Figure 13 illustrates the central role of
ubiquitous Na
+
i/K
+
i-sensitive regulators of gene expression such
as Fos, FosB, Jun, JunB, Atf3, Cyr61 in the triggering of diverse
cellular signals.
Figure 14 shows that cellular development, gene expression, cell
death, immunological and inflammatory responses are among top
altered biological functions controlled by ubiquitous Na
+
i/K
+
i-
sensitive transcriptome and mapped in this software with p,10
25.
Importantly, cellular responses triggered by differential expression
of Na
+
i,K
+
i-sensitive genes might be cell type-specific. Thus, for
example 24 hr incubation with ouabain resulted in death of renal
epithelial cells [23] but rescued RVSMC from apoptosis triggered
by serum deprivation [24].
Ca
2+-depletion increases the number of [Na
+]i/[K
+]i-
sensitive genes
Numerous studies have demonstrated that elevation of the
[Na
+]i/[K
+]i ratio heightens [Ca
2+]i via activation of Na
+
i/Ca
2+
o
exchanger as well as via depolarization and activation of voltage-
gated Ca
2+ channels (for review, see [9,10]). It has also been well-
documented that elevation of [Ca
2+]i affects gene expression by
activation of SRE via Ras-Raf-Erk-Elk1-mediated signaling, CRE
via phosphorylation of CRE binding protein and nuclear factor
AT (NFAT) binding sites via NFAT dephosphorylation by
calcineurin [7,25–27]. Unexpectedly, we found that in the
presence of extra- and intracellular Ca
2+ chelators (EGTA and
BAPTA, respectively) the number of cell type-specific and
ubiquitous Na
+
i,K
+
i-sensitive genes was increased rather than
decreased. Importantly, differential expression of more than 50%
of ubiquitous and cell type-specific Na
+
i,K
+
i-sensitive genes was
detected in Ca
2+-depleted cells only (Fig. 11). Furthermore, the
expression of several genes such as Fos, Zfp36, Jun and Dusp8 was
not affected or even activated in the presence of extra- and
intracellular Ca
2+ chelators (Fig. 12).
Recently, Akita and Okada reported that activation of volume-
sensitive anion channels in astrocytes by bradykinin was
suppressed by addition of BAPTA-AM at concentration higher
Table 3. Cont.
No. Gene symbol, title RVSMC HUVEC HeLa
Fold of activation/
inhibition
Fold of activation/
inhibition
Fold of activation/
inhibition
ouabain
K
+-free
medium ouabain
K
+-free
medium ouabain
K
+-free
medium
16o Hps6//Hermansky-Pudlak syndrome 6 22.1560.07 21.6960.10 21.3960.09 21.3160.10 21.4860.08 21.4660.06
17t Znf184//zinc finger protein 184 21.7860.06 21.5560.08 21.7160.10 22.0160.08 21.2860.07 21.4460.06
18t Pars2//prolyl-tRNA synthetase
(mitochondrial)(putative)
21.6160.04 21.2060.05 21.2860.05 21.2860.06 21.3860.05 21.3460.04
19o Sh3bp5l//SH3 binding domain protein 5 like 21.8260.04 21.5460.03 21.4660.07 21.4060.09 21.3560.07 21.2760.07
HeLa, HUVEC and RVSMC were treated with ouabain or K+-free medium for 3 hr. Genes whose expression is not affected by Na
+,K
+-ATPase inhibition at least in one type
of Ca
2+-depleted cells are shown in italics. Genes whose expression is not affected by Na
+,K
+-ATPase inhibition in all 3 types of cells are shown in underlined italics.
Functional categories are indicated in the left column as: t – regulators of transcription/translation, RNA processing and degradation; d – regulators of cell adhesion,
migration, proliferation, differentiation and death; f - protein folding and ubiquitination; i – inflammation and immune response; o – other functional categories and
genes with unknown function.
doi:10.1371/journal.pone.0038032.t003
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10 mM used in our study BAPTA-AM was unable completely
abolish elevation of [Ca
2+]i triggered by sustained inhibition of the
Na
+/K
+-ATPase. However, data listed below did not support this
assumption. First, 30 min incubation in Ca
2+-free medium
containing 10 mM BAPTA-AM and 50 mM EGTA sharply
suppressed or completely abolished an increment of [Ca
2+]i
triggered by activation of purinergic receptors (Fig. 7). Second,i n
contrast to overwhelming number of electrically excitable cells,
2 hr exposure of RVSMC to ouabain did not affect [Ca
2+]i but
Table 4. HeLa cells: the list of genes whose expression was changed by more than 4-fold in 3 hr of Na
+,K
+-ATPase inhibition in
control (Ca
2+ containing) medium.
Gene symbol, title Affymetrix ID
Fold of activation
or inhibition (-) by
ouabain/p value
Fold of activation or
inhibition (-) by K
+-free
medium/p value
Fold of activation by
ouabain/K
+-free medium
in HUVEC or RVSMC
EGR1//early growth response 1 8108370 13.78/7.27E-08 46.85/8.18E-05
FOS//FBJ murine osteosarcoma viral oncogene 7975779 5.88/7.27E-08 41.93/8.56E-06
FOSB//FBJ murine osteosarcoma viral oncogene 8029693 3.12/2.78E-07 23.85/1.51E-05
NR4A1//nuclear receptor subfamily 4, group A, 7955589 2.63/1.39E-07 11.79/8.56E-06 3.52/10.73 (HUVEC)
TNFAIP3//tumor necrosis factor, alpha-induced
protein 3
8122265 1.90/2.27E-07 11.77/8.56E-06 3.34/15.71 (HUVEC)
ATF3//activating transcription factor 3 7909610 2.28/9.86E-08 11.29/8.56E-06
EDN1//endothelin 1 8116921 2.31/2.55E-06 11.15/1.10E-04
NR4A3//nuclear receptor subfamily 4, group A 8156848 2.77/8.28E-08 11.06/8.56E-06 4.16/4.68 (HUVEC)
ZFP36//zinc finger protein 36, C3H type,
homolog (mouse)
8028652 2.27/9.86E-08 10.30/8.56E-06
IL8//interleukin 8 8095680 2.93/5.07E-06 10.00/5.31E-04 1.96/4.45 (HUVEC)
JUN//jun oncogene 7916609 1.91/1.68E-07 8.03/8.56E-06
IL6//interleukin 6 (interferon, beta 2) 8131803 2.01/3.12E-07 8.01/1.51E-05
PPP1R15A//protein phosphatase 1, regulatory
(inhibitor) subunit 15A
8030128 2.98/2.08E-06 7.73/5.19E-04
DUSP8//dual specificity phosphatase 8 7945641 1.83/4.85E-07 6.25/2.05E-05
EGR2//early growth response 2 7933872 1.85/1.39E-06 5.79/6.41E-05 2.87/9.08 (RVSMC)
DDIT3//DNA-damage-inducible transcript 3 7964460 1.52/2.19E-06 5.46/4.39E-05
JUNB//jun B proto-oncogene 8026047 2.20/5.35E-07 5.40/7.13E-05
PTGS2//prostaglandin-endoperoxide synthase 2 7922976 2.39/4.30E-06 5.15/9.30E-04
CYR61//cysteine-rich, angiogenic inducer, 61 7902687 2.02/2.78E-07 5.11/2.71E-05
CSRNP1//cysteine-serine-rich nuclear protein 1 8086330 2.32/2.88E-06 4.80/7.31E-04
HIST1H3J//histone cluster 1, H3j 8124537 1.69/2.25E-05 4.77/6.25E-04 1.40/1.62 (HUVEC)
NR4A2//nuclear receptor subfamily 4, group A, 8055952 2.39/1.39E-07 4.76/4.04E-05
NFKBIZ//nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, zeta
8081386 2.11/3.12E-07 4.66/5.06E-05
AREG//amphiregulin 8095744 2.10/2.01E-05 4.64/2.04E-03
DUSP1//dual specificity phosphatase 1 8115831 2.24/1.60E-07 4.64/4.09E-05 1.59/3.81 (HUVEC)
HES1//hairy and enhancer of split 1, (Drosophila) 8084880 1.71/1.05E-06 4.62/4.57E-05
SPRY4//sprouty homolog 4 (Drosophila) 8114797 2.12/3.80E-05 4.26/5.65E-03
TXNIP//thioredoxin interacting protein 7904726 3.07/6.87E-07 4.18/1.03E-02
DUSP10//dual specificity phosphatase 10 7924450 1.88/3.99E-07 4.04/4.71E-05 1.32/3.02 (HUVEC)
CDKN2AIP//CDKN2A interacting protein 8098500 1.84/2.19E-06 4.01/2.10E-04 1.26/2.05 (HUVEC)
ID2//inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
8040103 1.64/2.91E-06 4.01/1.25E-04
LOC100287934//similar to hCG2042721 7909990 22.41/2.12E-03 24.01/3.18E-05 21.96/24.68 (HUVEC)
LOC100131860//hypothetical protein 7991047 22.47/3.26E-03 24.73/3.32E-05
TRIM52//tripartite motif-containing 52 8110666 21.57/6.01E-03 25.03/8.88E-07 21.64/23.85 (HUVEC)
C9orf3//chromosome 9 open reading frame 3 8156571 22.85/4.40E-05 27.96/1.39E-07 21.71/22.24 (HUVEC)
Genes whose differential expression is limited to HeLa cells are shown in bold. Genes whose differential expression were also detected in HUVEC or RVSMC are shown
in underlined bold. All transcripts listed in this table were also differentially expressed in Ca
2+-depleted cells.
doi:10.1371/journal.pone.0038032.t004
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PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e38032Table 5. HUVEC: the list of genes whose expression was changed in by more than 4-fold in 3 hr of Na
+,K
+-ATPase inhibition in
control (Ca
2+ containing) medium.
Gene symbol, title Affymetrix ID
Fold of activation
or inhibition (-) by
ouabain/p value
Fold of activation
or inhibition (-) by
K
+-free medium/p
value
Fold of modulation
by ouabain/K
+-free
medium in HeLa or
RVSMC
EGR1//early growth response 1 8108370 9.69/1.10E-05 64.81/1.98E-08
FOS//FBJ murine osteosarcoma viral oncogene 7975779 2.60/2.41E-04 15.97/7.24E-08
TNFAIP3//tumor necrosis factor, alpha-induced
protein 3
8122265 3.34/7.23E-05 15.71/7.53E-08 1.90/11.77 (HeLa)
ZFP36//zinc finger protein 36, C3H type, 8028652 2.36/5.36E-04 12.07/1.99E-07
NUAK2//NUAK family, SNF1-like kinase, 2 7923753 2.22/3.28E-04 9.97/9.48E-08
IL1A//interleukin 1, alpha 8054712 3.30/5.79E-05 8.88/2.11E-07
CD274//CD274 molecule 8154233 3.71/1.71E-05 7.96/8.93E-08 1.42/2.31(HeLa)
PTGS2//prostaglandin-endoperoxide synthase 2 7922976 3.73/6.24E-08 7.84/1.12E-09
ATF3//activating transcription factor 3 7909610 1.86/7.23E-05 7.50/1.46E-08
JUNB//jun B proto-oncogene 8026047 1.85/6.08E-04 7.32/1.26E-07
TXNIP//thioredoxin interacting protein 7904726 2.62/3.51E-04 6.99/7.32E-07
ADAMTS1//ADAM metallopeptidase with
thrombospondin type 1 motif, 1
8069676 2.42/2.49E-04 6.31/4.46E-07
est (ncrna:misc_RNA) 7919749 2.20/4.60E-03 6.23/7.44E-06
HES1//hairy and enhancer of split 1, (Drosophila) 8084880 2.07/2.77E-04 5.86/2.11E-07
KITLG//KIT ligand 7965322 1.85/4.92E-05 5.85/1.70E-08
FOSB//FBJ murine osteosarcoma viral oncogene 8029693 1.99/6.50E-04 5.82/4.46E-07
Novel scRNA pseudogene 8160086 1.47/2.70E-02 5.64/1.49E-06
SNAPC1//small nuclear RNA activating complex,
polypeptide 1, 43 kD
7974870 2.17/2.13E-05 5.48/1.98E-08
NFKBIZ//nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, zeta
8081386 2.44/1.10E-05 5.15/2.16E-08
JUN//jun oncogene 7916609 1.94/3.43E-05 5.11/1.98E-08
FAM148B//family with sequence similarity 148,
member B
7989473 2.28/4.60E-03 5.09/2.05E-05
CXCL1//chemokine (C-X-C motif) ligand 1 8095697 2.03/2.26E-03 5.02/3.75E-06 2.97/4.02 (RVSMC)
SPRY4//sprouty homolog 4 (Drosophila) 8114797 3.27/5.05E-05 4.91/9.53E-07
DDIT3//DNA-damage-inducible transcript 3 7964460 1.35/1.12E-02 4.91/2.20E-07
HSPA1B//heat shock 70 kDa protein 1B 8178086 1.81/1.22E-02 4.78/1.22E-05
BIRC3//baculoviral IAP repeat-containing 3 7943413 1.69/5.91E-03 4.58/2.71E-06
KLF10//Kruppel-like factor 10 8152215 1.83/2.41E-04 4.53/1.34E-07
IL8//interleukin 8 8095680 1.96/2.61E-03 4.45/4.97E-06 2.93/10.00 (HeLa)
est (ncrna:snoRNA) 8126093 1.88/4.07E-04 4.41/4.46E-07
HSPA1A//heat shock 70 kDa protein 1A 8118310 1.85/7.33E-03 4.39/1.10E-05
SNORD3A//small nucleolar RNA, C/D box 3A 8005547 1.29/2.70E-02 4.31/4.46E-07
est (ncrna:misc_RNA) 8122816 1.52/8.96E-03 4.30/1.59E-06
PPP1R15A//protein phosphatase 1, regulatory
(inhibitor) subunit 15A
8030128 2.54/1.58E-04 4.08/1.26E-06
VIP//vasoactive intestinal peptide 8122865 1.53/4.54E-02 4.02/1.97E-05
KDM6B//lysine (K)-specific demethylase 6B 8004671 1.63/5.12E-03 4.01/2.53E-06 1.73/2.83 (HeLa)
SNORD52//small nucleolar RNA, C/D box 52 8118322 22.12/5.04E-03 24.14/2.96E-05
est (ncrna:snoRNA) 8012906 21.94/5.91E-04 24.39/8.68E-07
LOC100287934//similar to hCG2042721 7896754 21.93/2.58E-03 24.46/4.31E-06 22.41/24.01 (HeLa)
est (ncrna:misc_RNA) 8007990 21.37/4.92E-02 25.03/1.59E-06
Genes whose differential expression is limited to HUVEC are shown in bold. Genes whose expression were also detected in HeLa or RVSMC are shown in underlined
bold. Genes whose expression was not affected by Na
+,K
+-ATPase inhibition in Ca
2+-depleted cells are shown in italics.
doi:10.1371/journal.pone.0038032.t005
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PLoS ONE | www.plosone.org 12 May 2012 | Volume 7 | Issue 5 | e38032Table 6. RVSMC: the list of genes whose expression was changed by more than 4-fold in 3 hr of Na
+,K
+-ATPase inhibition in
control (Ca
2+ containing) medium.
Gene symbol, title Affymetrix ID
Fold of activation
or inhibition (-) by
ouabain/p value
Fold of activation or
inhibition (-) by K
+-free
medium/p value
Fold of modulation by
ouabain/K
+-free medium
in HUVEC or HeLa
Cxcl2//chemokine (C-X-C motif) ligand 2 10775896 3.44/7.21E-07 24.32/1.69E-09 1.38/2.58 (HUVEC)
Atf3//activating transcription factor 3 10770710 4.72/2.24E-07 20.63/2.72E-09
Fosb//FBJ osteosarcoma oncogene B 10719432 5.91/1.15E-06 15.22/4.45E-08
Btg2//B-cell translocation gene 2, anti-proliferative 10767767 5.28/1.08E-05 12.02/6.67E-07
Nr4a1//nuclear receptor subfamily 4, group A 10899387 3.52/2.89E-05 10.73/4.79E-07 2.63/11.79 (HeLa)
Csf2//colony stimulating factor 2 10742663 2.26/2.74E-05 10.35/4.23E-08
cDNA:known 10708091 3.89/1.50E-07 10.31/3.10E-09
Ptgs2//prostaglandin-endoperoxide synthase 2 10764551 9.46/1.08E-07 9.95/3.97E-08
Egr2//early growth response 2 10832802 2.87/2.64E-06 9.08/2.01E-08 1.85/5.79 (HeLa)
Fos//FBJ osteosarcoma oncogene 10886031 3.17/3.92E-06 8.76/5.28E-08
Lif//leukemia inhibitory factor 10773853 6.68/7.21E-07 8.68/1.47E-07
Nr4a2//nuclear receptor subfamily 4, group A 10845384 5.19/1.51E-06 8.65/1.47E-07
Axud1//AXIN1 up-regulated 1 10920967 5.10/7.51E-08 8.22/4.42E-09
Rgs2//regulator of G-protein signaling 2 10768332 2.41/6.15E-04 7.67/3.13E-06 1.31/2.65 (HUVEC)
Snf1lk//SNF1-like kinase 10832197 3.80/4.77E-06 7.55/2.42E-07
Birc3//baculoviral IAP repeat-containing 3 10914799 3.30/2.04E-08 7.47/3.66E-10
Egr1//early growth response 1 10800919 4.80/8.98E-06 6.97/1.76E-06
Plk2//polo-like kinase 2 (Drosophila) 10812954 2.14/1.27E-06 6.773.10E-09
Irf1//interferon regulatory factor 1 10733553 1.51/1.47E-04 6.33/1.70E-08
Hes1//hairy and enhancer of split 1 10754943 3.00/2.07E-06 6.15/5.28E-08
Egr3//early growth response 3 10781337 3.87/4.79E-07 6.00/4.45E-08
Zfp36//zinc finger protein 36 10720215 3.52/1.19E-06 5.95/7.06E-08
Txnip//thioredoxin interacting protein 10817552 3.85/1.47E-06 5.84/1.46E-07
Nfkbia//nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, alpha
10890024 2.46/3.55E-07 5.80/3.36E-09
Cish//cytokine inducible SH2-containing protein 10912908 3.59/8.97E-08 5.76/4.42E-09
Ier2//immediate early response 2 10806685 3.88/1.82E-06 5.26/2.80E-07
Hand1//heart and neural crest derivatives 10719358 1.86/7.51E-03 5.16/1.95E-05
Il6//interleukin 6 10859799 3.40/1.21E-05 4.76/2.03E-06
Nr4a3//nuclear receptor subfamily 4, group A 10868940 4.16/1.99E-05 4.68/9.44E-06 2.77/11.06 (HeLa)
Nfkbiz//nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor, zeta
10750848 3.24/8.70E-07 4.47/9.70E-08
Csf3//colony stimulating factor 3 (granulocyte) 10738051 7.04/2.47E-06 4.34/7.97E-06
Arrdc4//arrestin domain containing 4 10722720 2.39/2.99E-05 4.32/9.50E-07
Ddit3//DNA-damage inducible transcript 3 10895861 2.15/1.08E-07 4.26/1.52E-09
Junb//jun B proto-oncogene 10806585 4.03/2.54E-07 4.24/8.44E-08
Tiparp//TCDD-inducible poly(ADP-ribose) polymerase 10815763 2.64/1.51E-06 4.20/7.06E-08
Hbegf//heparin-binding EGF-like growth factor 10803947 4.44/1.55E-05 4.10/1.63E-05
Cxcl1//chemokine (C-X-C motif) ligand 1 10775900 2.97/3.28E-07 4.02/3.72E-08 2/03/5.02 (HUVEC)
Ttc30b//tetratricopeptide repeat domain 30B 10846293 24.13/3.19E-05 21.44/4.97E-02 21.38/21.54 (HUVEC)
Gemin4//gem (nuclear organelle) associated protein 10745022 24.08/2.21E-06 22.10/6.59E-05
RGD1566325//similar to regulator of sex-limitation
candidate 16
10796900 24.15/4.85E-06 22.16/1.38E-04
est (ncrna: snoRNA) 10765034 21.99/1.58E-06 25.01/4.91E-09
est (ncrna: snoRNA) 10713606 23.21/2.51E-06 25.56/1.42E-07
est (ncrna: snoRNA) 10713604 23.37/7.17E-06 27.34/2.44E-07
Genes whose differential expression is limited to RVSMC are shown in bold. Genes whose expression were also detected in HeLa or HUVEC are shown in underlined
bold. Genes whose expression was not affected by Na
+,K
+-ATPase inhibition in Ca
2+-depleted cells are shown in italics.
doi:10.1371/journal.pone.0038032.t006
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Here, we demonstrated that addition of 50 mM EGTA and 10 mM
BAPTA-AM completely abolished a modest increment of [Ca
2+]i
triggered by 3 hr incubation of HeLa cells with ouabain whereas
augmented expression of EGR1, PTGS2 and PPP1R15A was
preserved (Table 8). Third, in the presence of 10 mM BAPTA-AM,
intracellular concentration BAPTA in HeLa cells reached a value
of ,130 mM (Table 8). Based on the volume of intracellular water
(,2 ml/mg of protein), the intracellular BAPTA content on these
cells (,260 pmol/mg protein) was sufficient to bind the total pool
of intracellular exchangeable calcium (,200 pmol/mg protein)
[13]. Fourth, elevation of intracellular [BAPTA] up to ,700 mM
did not abolished increments of gene expression evoked by
ouabain (Table 8). It is important to note that long-term exposure
of cells to Ca
2+ chelators at higher concentrations causes diverse
side-effects including elevated permeability of the plasma mem-
brane for Na
+ [20]. Moreover, because of the high affinity to other
di- and trivalent cations [29], Ca
2+ chelators can affect
transcriptome via irreversible conformational transition and
inactivation of transcriptional adaptor Zn
2+-binding domain
[30]. Viewed collectively, these data strongly indicate that besides
canonical Ca
2+-mediated signalling, gain of [Na
+]i and/or loss of
[K
+]i influence gene expression via Ca
2+
i-independent mecha-
nism.
Physiological and pathophysiological implications
The Na
+
i/K
+
i-dependent regulation of gene expression may
have numerous physiological and pathological implications
(Fig. 15). Here, we discuss a few of tissue-specific examples.
Excitation of neuronal cells. Almost 30 years ago, several
research teams reported that expression of Erg1 and other
Na
+
i,K
+
i-sensitive IGR listed in Table 2 is strongly increased in
neuronal cell subjected to excitation by diverse stimuli including
neurotransmitters, depolarization and light [31–33]. The mecha-
nisms of this phenomenon, widely employed for the identification
of excited brain areas, remain largely unknown. It has been shown
that activation of N-methyl-D-aspartate (NMDA) receptor con-
tributes to elevation of Egr1 mRNA content in excited neuronal
cells. This link is so prominent that monitoring Egr1 expression has
been proposed as a biological assay for NMDA receptor activity.
Given a key role of NMDA receptor activation in regulating
synaptic strength, Egr1 accumulation has also been connected with
learning and memory (for review, see [34]). Indeed, experiments
performed on Egr1 deficient mice showed that their inability to
form long-term memory in a variety of behavioural tasks [35]. It is
generally accepted that Egr1 expression in neuronal cells is
triggered by [Ca
2+]i elevation [25]. However, ion currents through
NMDA channels are mainly mediated by monovalent cations
(PNa,PK&PCa), and short periods of synaptic activity in apical
dendrites and dendritic spines produce increases in [Na
+]i, from
,10 to 30 and 100 mM, respectively [36]. Recently, sharp
elevation of [Na
+]i in response to local application of glutamate
was demonstrated in neocortical neurons loaded with sodium-
sensitive nanoprobe [37]. Here, we report that elevation of the
[Na
+]i/[K
+]i ratio in Ca
2+-depleted HUVEC and HeLa cells
augmented Egr1 expression by ,10-fold, which is comparable to
increments detected in Ca
2+-containing medium (Tables 4,5). In
contrast, in RVSMC, Egr1 up regulation was exclusively detected
in the presence of Ca
2+ (Table 6). Therefore, the relative impact of
Ca
2+
i- mediated and Ca
2+
i -independent mechanisms on Egr1
expression triggered by elevation of the [Na
+]i/[K
+]i ratio in
neuronal cells and their roles in memory formation and storage
should be further examined in light of the data presented here.
Figure 7. Effect of EGTA and BAPTA on Ca2+ signalling triggered by activation of purinergic receptors. A. Representative records
showing kinetics of elevation of intracellular Ca
2+-concentration (F340/F360 ratio) in HeLa cells triggered by addition of 100 mM ATP. 1 – Control (Ca
2+-
containing medium); 2 – cells were preincubated for 10 min in Ca
2+-free medium containing 50 mM EGTA and 10 mM BAPTA-AM. B. Baseline and
maximal values of [Ca
2+]i in ATP-treated HeLa, HUVEC and RVSMC in control and Ca
2+-free medium containing 50 mM EGTA and 10 mM BAPTA-AM.
Mean 6 S.E. values obtained in 4 experiments are shown.
doi:10.1371/journal.pone.0038032.g007
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+,K
+-ATPase inhibition by ouabain and K
+-free medium on the transcriptome of
Ca
2+-depleted HeLa, HUVEC and RVSMC. A. Principal component analysis of HeLa, HUVEC and RVSMC transcriptomes. Cells were incubated for
3h ri nC a
2+-free medium containing 50 mM EGTA and 10 mM BAPTA-AM and processed for oligonucleotide microarray analysis as indicated in the
Methods section. Ouabain was added at a final concentration of 3 mM (HeLa and HUVEC) or 3 mM (RVSMC). Ellipsoids highlight portioning of samples
based on the type of cell treatment. The principal components in 3-dimensional graphs (PC#1, PC#2 and PC#3) represent the variability in gene
expression level within datasets. The total percentage of PCA mapping variability is shown on top. B. Total numbers of genes whose expression is
altered by ouabain and K
+-free medium by more than 1.2-fold with p,0.05 are indicated; numbers of genes affected by both stimuli appears in bold.
doi:10.1371/journal.pone.0038032.g008
Figure 9. Correlation analysis of transcripts whose expression is altered by ouabain and K
+-free medium in Ca
2+-depleted HeLa,
HUVEC and RVSMC more than by 1.2-fold with p,0.05. Cells were incubated during 3 hr in Ca
2+-free medium containing 50 mM EGTA and
10 mM BAPTA-AM. Ouabain was added at a final concentration of 3 mM (HeLa and HUVEC) or 3 mM (RVSMC). The total number of transcripts
subjected to analysis is shown in Figure 8B. Transcript expression in control cells was taken as 1.00.
doi:10.1371/journal.pone.0038032.g009
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plasma concentration of IL6 increases up to 100-fold during
muscular exercise. This increase is followed by the expression of
the IL1 receptor agonist (Il1ra) and the anti-inflammatory cytokine
IL10. Importantly, contracting skeletal muscle rather than the
immune cells is the only source of the IL6 in circulation in
response to exercise. The mechanism of this phenomenon, which
plays a key role in the energy supply via elevation of glucose
Figure 10. Na
+
i,K
+
i-sensitive transcriptomes identified in Ca
2+-depleted cells. A. Pie-chart showing the numbers of and cell type-specific,
Na
+
i,K
+
i-sensitive genes detected in HeLa, HUVEC and RVSMC and ubiquitous Na
+
i,K
+
i-sensitive genes found in all 3 types of cells. Experiments were
performed in Ca
2+-free medium containing 50 mM EGTA and 10 mM BAPTA-AM. B. The distribution of ubiquitous and cell type-specific Na
+
i,K
+
i-
sensitive among major functional groups. Digitals shown in italics correspond to gene numbers in each functional group.
doi:10.1371/journal.pone.0038032.g010
Table 7. Total numbers of differentially expressed transcripts in HeLa, HUVEC and RVSMC in 3-hr of Na
+,K
+-ATPase inhibition in
Ca
2+-free medium containing extra- and intracellular Ca
2+ chelators.
Ouabain-treated cells Cells treated with K
+-free medium Transcripts affected by both stimuli
HeLa
Up-regulated transcripts
Number of transcripts 1007 1633 755
Maximal fold of activation 13.52 28.33 N.A.
Down-regulated transcripts
Number of transcripts* 1204 1868 996
Maximal fold of inhibition 5.18 9.31 N.A.
HUVEC
Up-regulated transcripts
Number of transcripts 1521 1696 1177
Maximal fold of activation 12.58 19.96 N.A.
Down-regulated transcripts
Number of transcripts* 1631 1813 1329
Maximal fold of inhibition 8.19 10.91 N.A.
RVSMC
Up-regulated transcripts
Number of transcripts 2342 3107 1911
Maximal fold of activation 7.60 10.17 N.A.
Down-regulated transcripts
Number of transcripts* 1835 2400 1543
Maximal fold of inhibition 13.49 12.91 N.A.
Transcripts whose expression was altered by more than 1.2-fold with p,0.05 were subjected to analysis. EGTA and BAPTA-AM were added at concentrations of 50 and
10 mM, respectively. Ouabain was added at final concentration of 3 mM (HeLa and HUVEC) or 3 mM (RVSMC). N.A. – non-applicable.
doi:10.1371/journal.pone.0038032.t007
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poorly understood (for comprehensive review, see [38]). It is
known, however, that in both humans and experimental animals,
intensive exercise increases [Na
+]i in skeletal muscles by 3–4-fold
and decreases [K
+]i by 15–25% via activation of voltage-gated K
+
and Na
+ channels and partial inactivation of Na
+,K
+-ATPase
[39,40]. Here, we demonstrated that Il6 is among the ubiquitous
genes whose expression is strongly increased by elevation of the
[Na
+]i/[K
+]i ratio (Table 3). Therefore, our data allow us
hypothesize that elevation of plasma level of IL6 during intensive
exercise is caused by elevation of the [Na
+]i/[K
+]i ratio in skeletal
muscle that, in turn, increases expression of the [Na
+]i/[K
+]i-
sensitive genes, including Il6.
Ischemia. To date, transcriptomic alterations in response to
oxygen deprivation, such as modest hypoxia in solid tumours or in
the adipose tissue of obese patients, have been largely ascribed to
the overexpression of hypoxia-inducible factor 1 (HIF-1) known to
be the molecular pO2 sensor that affects gene expression via its
binding to cis-acting hypoxic-response elements (HRE) [41]. It
should be noted, however, that the overwhelming number of
genes, such as Egr1, Atf3, Ptgs2, Il6, Ppp1r5, Hes1, Nfkbiz, Txnip,
Adamts1, Egr 3, Cxcl2, Hsp70, whose expression is strongly
increased in cells subjected to ischemia/reperfusion both in vivo
and in vitro [42–52], lack HRE. Significantly, we detected the
above-listed genes among ubiquitous (Egr1, Atf3, Ptgs2, Il6, Ppp1r5,
Hes1, Nfkbiz, Txnip, Tables 3 and 9) or cell-type specific (Adamts1,
Egr 3, Cxcl2, Hsp70, Table 4,5,6) [Na
+]i/[K
+]i-sensitive genes.
Since even transient ischemia increases [Na
+]i from 5–8 to 25–
40 mM and causes reciprocal changes in [K
+]i [53], it can be
hypothesized that inversion of the [Na
+]i/[K
+]i ratio contributes to
transcriptomic changes triggered by ischemia, with pathways that
are complementary to those previously associated with activation
of HIF-1. This conclusion is consistent with IPA Knowledge Base
data showing abnormalities of gene expression revealed in
ischemic liver, heart and kidney among disorders linked with
ubiquitous Na
+
i/K
+
i-sensitive transcriptome (Fig. 16).
In conclusion, we report here that elevation of the [Na
+]i/[K
+]i
ratio affects expression of hundreds of genes via the activation of
Ca
2+-mediated and most importantly Ca
2+-independent signaling
pathways. The proposed hypothetical hierarchy of these pathways
Figure 11. Pie-chart showing the action of Ca
2+ depletion on Na
+
i,K
+
i-sensitive transcriptomes. Ca
2+-depletion was triggered by omission
of extracellular Ca
2+ and addition of 50 mM EGTA and 10 mM BAPTA-AM. The numbers of ubiquitous Na
+
i,K
+
i-sensitive genes and Na
+
i,K
+
i-sensitive
genes detected in HUVEC, HeLa and RVCSM are shown in italics.
doi:10.1371/journal.pone.0038032.g011
Table 8. Intracellular concentration of BAPTA, Ca
2+ and expression of EGR1, PTGS2 and PPP1R15A in HeLa cells.
Incubation medium Ouabain, mM
Intracellular [BAPTA],
mM[ C a
2+]i,n M Gene expression, arbitrary units,
EGR1 PTGS2 PPP1R15A
1. Control 0 ND 121612 1.0 1.0 1.0
3N D 1 6 4 611* 56.462.3*** 6.160.8*** 9.361.1***
2. Ca
2+-free+10 mM0 1 2 7 633 97686 . 0 60.6 1.960.3 1.360.2
BAPTA-AM 3 ND 92614 59.961.7*** 4.860.7** 5.160.7**
3. Ca
2+-free+100 mM0 7 3 5 6101 91615 9.360.8 2.560.3 2.260.4
BAPTA-AM 3 ND 10469 55.263.4*** 7.260.8** 6.460.5***
HeLa cells were incubated during 3 hrs with or without ouabain in control medium containing 1.8 mM CaCl2 (1)o ri nC a
2+-free medium containing 50 mM EGTA and 10
or 100 mM BAPTA-AM (2 and 3, respectively). Changes in the expression of of EGR1, PTGS2 and PPP1R15A were measured by qRT-PCR. For more details, see Methods
section. Means 6 S.E. obtained in experiments performed in quadruplicate are shown. ND – these values were not determined.
*, ** and ***- p,0.05, 0.01 and 0.001 compared to values obtained in the absence of ouabain, respectively.
doi:10.1371/journal.pone.0038032.t008
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PLoS ONE | www.plosone.org 17 May 2012 | Volume 7 | Issue 5 | e38032Table 9. Genes whose expression was changed in HeLa, HUVEC and RVSMC by more than 1.2-fold (p#0.05) in 3 hr of Na
+,K
+-
ATPase inhibition in Ca
2+-free medium containing extra- and intracellular Ca
2+ chelators.
No. Gene symbol, title WKY-7 HUVEC HeLA
Fold of activation by Fold of activation by Fold of activation by
ouabain
K
+-free
medium Ouabain
K
+-free
medium ouabain
K
+-free
medium
Up-regulated genes
1t Fos//FBJ osteosarcoma oncogene 6.1160.12 6.9760.10 11.0560.14 19.6860.13 13.5260,10 28.3360,08
2t Zfp36//zinc finger protein 36 2.7760.06 3.4260.06 12.5860.06 15.1060.09 8.3460,11 13.8360,10
3t Fosb//FBJ osteosarcoma oncogene B 4.0760.11 5.6060.11 2.7060.11 4.3060.07 3.7360,12 11.0960,06
4t Nr4a1//nuclear receptor subfamily 4, group A,
member 1
1.3660.06 1.8360.07 1.3160.03 1.7760.04 4.2360,09 8.7560,09
5t Jun//Jun oncogene 1.7560.04 2.1660.03 3.4660.06 4.7660.06 3.8160,10 8.1860,08
6d Dusp8//dual specificity phosphatase 8 2.3460.05 2.0760.05 3.5960.11 4,7360.07 3.2660,10 6.3160,12
7d Btg2//B-cell translocation gene 2, anti-proliferative 3.6860.07 4.4460.08 1.4260.11 1.5960.11 2.5160,11 5.3660,06
8d Cyr61//cysteine-rich, angiogenic inducer, 61 1.5860.04 1.6160.04 2.1660.05 2.4360.05 3.0460,09 4.9460,09
9d Ppp1r15a//protein phosphatase 1, regulatory
(inhibitor) subunit 1
1.3360.08 1.5960.07 1.4860.07 1.6360.07 2.5960,11 3.9260,10
10d Nuak2//NUAK family, SNF1-like kinase, 2 1.4460.09 1.9560.07 2.9160.12 4.1860.14 1.7860,10 3.8560,09
11t Hes1//hairy and enhancer of split 1 (Drosophila) 3.5660.05 4.0760.05 2.6960.02 2.9660.02 2.7560,04 3.7760,05
12i Adamts1//ADAM metallopeptidase with
thrombospondin type 1 motif
2.0660.07 2.7760.07 1.6060.07 2.5460.09 2.6260,07 3.5660,08
13d Rhob//ras homolog gene family, member B 1.7260.09 1.7460.10 1.3360.03 1.5260.04 2.1060,08 3.3160,07
14t Id2//inhibitor of DNA binding 2 1.2960.08 1.3160.07 1.9360.08 2.7160.11 1.7760,09 3.2960,06
15o Adm//adrenomedullin 3.2860.10 4.2560.09 3.0760.05 3.7660.07 2.0160,09 3.2160,06
16d Dusp1//dual specificity phosphatase 1 5.4560.10 6.9060.10 2.7160.06 3.2960.06 2.3460,05 3.1360,04
17i Nfkbia//nuclear factor of kappa light polypeptide
gene
2.5360.03 3.2560.04 1.7760.04 2.1860.09 1.8360,08 3.0760,08
18t Ier2//immediate early response 2 1.3060.02 1.4860.06 1.8260.05 2.0560.06 2.0360,07 2.8660,06
19i Nfkbiz//nuclear factor of kappa light polypeptide
gene
1.2960.06 1.5160.07 2.4460.05 3.1960.05 2.1860,04 2.6460,04
20d Dusp10//dual specificity phosphatase 10 1.5860.04 2.0860.03 1.5660.06 2.1460.04 1.9960,09 2.5960,06
21o Tiparp//TCDD-inducible poly(ADP-ribose) polymerase 1.9260.04 2.0160.04 2.0160.04 2.3160.04 1.8960,04 2.5760,04
22d Plk3//polo-like kinase 3 (Drosophila) 1.4860.04 1.5160.04 1.5260.06 1.7960.09 1.7960,06 2.5260,06
23o Il6//interleukin 6 1.8460.11 2.0060.11 1.4260.03 1.2760.07 1.3960,13 2.4560,14
24t Maff//v-maf musculoaponeurotic fibrosarcoma
oncogene homolog F
2.4560.12 2.6460.11 2.2160.05 2.2760.05 1.7860,07 2.2460,08
25o Ptgs2//prostaglandin-endoperoxide synthase 2 1.7860.04 2.1160.03 1.8360.06 2.1260.06 1.8260,09 2.2360,06
26t Jund//Jun D proto-oncogene 1.3860.04 1.5260.04 1.7360.05 1.9660.07 1.4760,10 2.1660,11
27t Rgs2//regulator of G-protein signaling 2 1.3560.07 1.7260.08 2.3160.07 2.9960.07 1.3360,08 2.1460,09
28d Ccnl1//cyclin L1 1.7660.04 1.7260.04 1.8960.06 2.1160.04 1.5260,05 2.1060,03
29o Dusp16//dual specificity phosphatase 16 1.3860.04 1.2860.03 2.3460.07 3.4360.09 1.4360,07 2.0260,11
30d Lats2//large tumor suppressor 2 1.4660.06 1.3960.06 1.4360.03 1.5160.03 1.5560,06 1.9460,07
31o Insig1//insulin induced gene 1 1.3160.03 1.4260.03 1.8160.03 2.0660.03 1.5060,03 1.8960,03
32d Gadd45b//growth arrest and DNA-damage-inducible,
beta
1.4460.08 1.7160.06 1.6860.06 1.7260.08 1.2360,09 1.8760,07
33d Abl2//v-abl Abelson murine leukemia viral
oncogene homolog 2
2.2160.06 1.8660.06 1.3860.03 1.5260.03 1.5160,07 1.8460,09
34o Cd68//Cd68 molecule 2.5260.17 1.5260.16 1.3160.09 1.2260.10 1.3860,07 1.8360,05
35d Skil//SKI-like oncogene 1.4460.04 1.4560.05 1.3660.05 1.5260.05 1.4060,07 1.7860,05
36t Crem//cAMP responsive element modulator 1.3260.06 1.6560.05 1.5160.03 1.6460.05 1.4560,04 1.6860,05
37d Wee1//wee 1 homolog (S. pombe) 1.4860.06 1.3060.07 1.5260.04 1.6860.05 1.4860,03 1.6360,04
38f Yod1//YOD1 OTU deubiquinating enzyme 1
homolog (S. cerevisiae)
1.3260.06 1.3160.04 1.3760.04 1.2260.04 1.5560,07 1.6360,07
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39d Cd274//CD274 molecule 1.3160.06 1.3060.06 4.6060.10 6.8160.10 1.5460,05 1.6160,09
40d Hspg2//heparan sulfate proteoglycan 2 1.8760.03 1.9960.04 1.3660.04 1.3560.04 1.4860,05 1.5860,05
41o Slc19a2//solute carrier family 19 (thiamine transporter) 1.2960.02 1.3860.06 1.6060.06 1.5660.06 1.6260,07 1.5560,07
42o Zswim6//zinc finger, SWIM-type containing 6 1.2660.05 1.3360.05 1.4760.02 1.5660.03 1.3760,02 1.4960,02
43o Agrn//agrin 1.8960.04 1.9260.03 1.7360.06 1.6360.08 1.3460,05 1.4960,05
44o Neu1//sialidase 1 (lysosomal sialidase) 1.2860.07 1.4960.07 1.2960.09 1.2660.12 1.3860,07 1.4860,05
45d Ptprj//protein tyrosine phosphatase, receptor type 1.7960.05 1.8160.06 1.5360.06 1.4760.06 1.3960,03 1.4760,03
46o Pfkfb4//6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 4
1.2360.04 1.2660.04 1.2960.07 1.3060.07 1.2760,08 1.4660,05
47o Lama5//laminin, alpha 5 1.3760.03 1.4560.03 1.5560.04 1.5560.06 1.2460,04 1.4660,06
48d Cdc26//cell division cycle 26 2.1060.09 2.1260.08 1.5660.05 1.6260.09 1.4760,05 1.4660,06
49t Cbx6//chromobox homolog 6 1.6060.03 1.7460.04 1.5960.04 1.4960.04 1.3860,03 1.4260,04
50d Cnnm4//cyclin M4 1.2760.08 1.3760.06 1.3160.03 1.3760.07 1.2160,09 1.4260,09
51o Txnip//thioredoxin interacting protein 3.8160.07 3.7260.07 3.2360.05 2.4060.08 1.3160,06 1.4060,04
52f Skp1//S-phase kinase-associated protein 1 1.3060.04 1.3060.03 1.4160.08 1.5260.09 1.3060,05 1.3860,05
53d Ltbp2//latent transforming growth factor beta binding
protein 2
1.2760.03 1.3260.04 1.2460.04 1.2160.04 1.2760,04 1.3760,04
54o B4galt5//UDP-Gal:betaGlcNAc beta 1,4-
galactosyltransferase
1.6060.03 1.7960.03 1.2860.02 1.2060.02 1.4260,02 1.3660,03
55i Relt//RELT tumor necrosis factor receptor 1.5160.05 1.3160.05 1.3360.05 1.2560.07 1.3960,03 1.3660,07
56t Rfx1//regulatory factor X, 1 (influences HLA class II
expression)
1.2960.07 1.2360.07 1.3660.11 1.2760.10 1.3160,04 1.3460,08
57o Pip5k1c//phosphatidylinositol-4-phosphate 5-kinase,
type I
1.2660.05 1.2960.05 1.2560.06 1.2360.06 1.2360,02 1.3360,06
58d Efhd2//EF-hand domain family, member D2 1.2360.04 1.3660.04 1.5360.09 1.5260.11 1.2360,04 1.3260,07
59o Slc16a3//solute carrier family 16, member 3 2.1760.11 2.3060.11 1.3660.07 1.3060.07 1.2660,04 1.3260,06
60d Ccnd1//cyclin D1 1.2560.03 1.3360.03 1.4260.04 1.3560.03 1.2560,03 1.3260,04
61o Gla//galactosidase, alpha 1.7260.03 1.6160.06 1.3460.09 1.5060.07 1.3160,06 1.3060,08
62o Abca2//ATP-binding cassette, sub-family A (ABC1),
member 2
1.4860.04 1.4560.05 1.3760.05 1.2860.07 1.2260,04 1.2760,04
63o Epha4//Eph receptor A4 2.0360.08 2.2860.09 1.6760.06 1.8360.06 1.2860,06 1.2760,08
64t Nfya//nuclear transcription factor-Y alpha 1.4060.06 1.2760.05 1.3560.02 1.3060.07 1.4760,06 1.2660,05
65o Megf9//multiple EGF-like-domains 9 1.4060.05 1.5560.05 1.2760.07 1.2960.07 1.2660,04 1.2660,08
66t Arid3b//AT rich interactive domain 3B (Bright like) 1.4660.05 1.2460.05 1.5760.07 1.5160.07 1.2960,11 1.2660,10
67o Pnkd//paroxysmal nonkinesiogenic dyskinesia 1.5560.08 1.7160.08 1.4260.05 1.2760.07 1.2860,04 1.2660,05
68t Sart3//squamous cell carcinoma antigen recognized
by T-cells 3
1.3460.05 1.2860.05 1.5360.04 1.4960.04 1.2360,08 1.2460,05
69o Myl6//myosin, light chain 6, alkali, smooth muscle
and non-muscle
1.2260.01 1.2460.01 1.2260.04 1.2260.04 1.3060,04 1.2360,04
70o Slc2a12//solute carrier family 2 (facilitated glucose
transport)
1.4560.07 1.5860.06 1.3460.09 1.4560.10 1.3460,08 1.2260,05
Down-regulated genes
1d Chac1//ChaC, cation transport regulator homolog 1
(E. coli)
21.8060.07 22.2160.10 24.0760.12 25.1760.20 25.1860,09 29.3160,11
2f Herpud1//homocysteine-inducible, endoplasmic
reticulum stress-ind
22.6660.06 23.0360.05 22.3060.06 23.1260.05 21.9560,07 22.6460,07
3t Sdf2l1//stromal cell-derived factor 2-like 1 21.8260.07 21.6360.07 23.0360.04 23.6760.03 21.8060,08 22.3660,05
4t Hoxb5//homeo box B5 21.5760.11 21.5360.11 21.9660.06 22.1960.08 21.9260,06 22.3360,04
5o Asns//asparagine synthetase 21.3460.05 21.4360.04 21.6760.06 21.6760.09 21.6460,07 21.9660,04
6t Trnt1//tRNA nucleotidyl transferase, CCA-adding, 1 21.3760.14 21.6960.08 21.2060.06 21.2560.07 21.5160,10 21.9460,07
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7f Dnajc3//DnaJ (Hsp40) homolog, subfamily C,
member 3
22.1260.06 22.1760.05 22.2560.04 22.5160.03 21.7260,06 21.9160,06
8t Cebpg//CCAAT/enhancer binding protein (C/EBP),
gamma
21.3060.04 21.4560.03 21.8160.06 21.9160.05 21.4760,07 21.9160,08
9o Riok2//RIO kinase 2 (yeast) 21.6860.05 21.6060.05 21.5960.06 21.5360.06 21.6160,06 21.8960,08
10o Ficd//FIC domain containing 24.6260.09 24.5960.08 23.7560.15 23.7960.17 21.7160,09 21.8760,09
11o Pdia4//protein disulfide isomerase family A, member 4 21.8260.05 21.7060.05 21.5860.04 21.6760.04 21.6460,07 21.8660,07
12o Pck2//phosphoenolpyruvate carboxykinase 2
(mitochondrial)
21.5060.05 21.4960.05 21.9560.05 22.0660.08 21.7960,05 21.8660,06
13t Cars//cysteinyl-tRNA synthetase 21.4160.04 21.9760.04 21.6760.05 21.8960.06 21.5160,10 21.8560,09
14d Dnajb9//DnaJ (Hsp40) homolog, subfamily B,
member 9
21.9160.05 22.0960.06 24.3060.11 24.8760.07 21.7360,10 21.8060,08
15o Stc2//stanniocalcin 2 21.9960.03 22.0360.05 23.3560.07 23.4060.09 22.1760,10 21.7960,11
16o Zbed3//zinc finger, BED-type containing 3 21.5260.11 21.3360.10 21.6560.08 21.8860.07 21.5660,09 21.7660,12
17o Rpp40//ribonuclease P 40 subunit (human) 21.3560.08 21.4060.09 21.4660.04 21.2460.05 21.3160,07 21.7460,07
18t Trim27//tripartite motif-containing 27 21.8760.07 21.8460.06 21.4560.03 21.3060.03 21.5960,05 21.7260,07
19f Hyou1//hypoxia up-regulated 1 22.2460.08 22.2560.08 21.7160.05 21.8760.05 21.4260,04 21.7160,04
20t Mrpl46//mitochondrial ribosomal protein L46 21.3460.05 21.3560.06 21.3660.04 21.6060.05 21.3360,04 21.7060,09
21t Xbp1//X-box binding protein 1 21.6760.04 21.8660.03 21.4660.07 21.6160.07 21.3060,05 21.7060,04
22f Sel1l//sel-1 suppressor of lin-12-like (C. elegans) 21.5860.07 21.7460.07 22.2060.01 22.3760.02 21.5760,06 21.6860,07
23o Ankrd49//ankyrin repeat domain 49 21.4360.04 21.3360.06 21.5060.11 21.4960.08 21.5160,10 21.6660,08
24o Lin37//lin-37 homolog (C. elegans) 21.4060.06 21.3460.04 21.4560.06 21.6260.05 21.4660,06 21.6460,07
25t Alkbh8//alkB, alkylation repair homolog 8 (E. coli) 21.9260.05 21.9260.07 21.3760.07 21.2660.05 21.3760,10 21.6460,08
26o Gpt2//glutamic pyruvate transaminase 21.3560.07 21.3860.08 21.6460.06 21.5860.05 21.7060,08 21.6360,04
27o Kctd6//potassium channel tetramerisation domain
containing 6
21.8060.10 21.6560.09 21.5160.07 21.6960.13 21.4160,08 21.6260,08
28t Hoxb6//homeo box B6 21.6060.08 21.5860.08 21.3860.10 21.3360.08 21.3860,07 21.5860,08
29d Ddit4//DNA-damage-inducible transcript 4 22.2960.02 21.9760.05 25.0960.10 23.6960.13 21.8460,05 21.5860,06
30o Slc25a28//solute carrier family 25, member 28 21.8560.05 21.8360.04 21.4160.07 21.5360.07 21.2860,06 21.5760,05
31o Cth//cystathionase (cystathionine gamma-lyase) 22.5160.05 22.6260.06 22.2260.09 22.2060.12 21.8960,09 21.5460,09
32f Rnf217//ring finger protein 217 21.3160.09 21.3360.09 22.7360.08 22.8660.05 21.2860,09 21.5360,10
33f Rnf146//ring finger protein 146 21.3060.02 21.2160.03 21.4360.03 21.5960.06 21.3560,05 21.5060,07
34f Fbxo42//F-box protein 42 21.4260.05 21.4160.05 21.3860.04 21.4160.05 21.4360,04 21.5060,06
35o Creld2//cysteine-rich with EGF-like domains 2 23.2760.09 22.9960.08 21.5560.05 21.5160.05 21.5060,06 21.4960,07
36f Hspa5//heat shock protein 5 21.2860.03 21.2360.03 21.5760.03 21.7260.01 21.4260,04 21.4860,07
37o Ttc14//tetratricopeptide repeat domain 14 21.2360.08 21.4160.06 21.4260.04 21.6960.06 21.2760,06 21.4860,08
38d Trib3//tribbles homolog 3 (Drosophila) 22.6060.03 23.8660.06 21.2660.05 21.4160.07 21.2660,07 21.4660,07
39d Jag1//jagged 1 21.4560.04 21.7660.02 21.3660.04 21.3360.05 21.3960,04 21.4560,05
40d Esco1//establishment of cohesion 1 homolog 1 (S.
cerevisiae)
21.4060.04 21.4360.04 21.3660.09 21.2160.08 21.6660,12 21.4560,10
41t Exosc3//exosome component 3 21.2960.06 21.2560.06 21.4660.06 21.3360.06 21.2760,10 21.4460,12
42o Slc33a1//solute carrier family 33 (acetyl-CoA
transporter)
21.8860.10 22.2160.09 21.9260.08 21.8960.06 21.4160,05 21.4460,06
43d Tbccd1//TBCC domain containing 1 21.3560.06 21.2860.04 21.3860.04 21.4060.08 21.4160,06 21.4460,03
44o Znf509//zinc finger protein 509 21.3960.04 21.2660.04 21.4260.12 21.2960.10 21.4160,02 21.4360,07
45o Slc25a37//solute carrier family 25, member 37 22.1760.05 21.8960.07 21.2560.05 21.2060.06 21.3360,06 21.4260,06
46f Dnajb11//DnaJ (Hsp40) homolog, subfamily B,
member 11
21.3360.05 21.2560.03 21.6260.06 21.8060.04 21.2860,05 21.4260,06
47f Fem1b//feminization 1 homolog b (C. elegans) 21.7160.03 21.6060.03 21.3760.05 21.3960.05 21.3160,04 21.3960,04
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Na
+
i rather than loss of K
+
i triggers augmented c-Fos expression in
RVSMC [12]. We also reported that c-Fos expression triggered by
[Na
+]i elevation occurs via Ca
2+
i-independent signaling mecha-
nism that is not mediated by any known transcriptional elements
in 59-promoter [13]. We firmly believe that the newly gained
knowledge of the Na
+
i/K
+
i-sensitive transcripts (genes X1,2,3…,
Fig. 15) will allow researchers to take powerful bioinformatics
approaches to identify previously-unfamiliar Ca
2+
i-independent
mechanism of the excitation-transcription coupling as well as its
involvement in cellular responses triggered by sustained elevation
of the [Na
+]i/[K
+]i ratio.
Methods
Cell cultures
We studied three cell types in the experiments reported here.
RVSMC cells were isolated from rat aortae according to the
procedures outlined in the Guide for the Care and Use of Experimental
Animals endorsed by the Canadian Institutes of Health Research
and accepted by the Institutional Animal Protection Committee of
the CRCHUM. These cells maintain a number of characteristics
of primary cultured RVSMC including high expression of smooth
muscle-specific a-actin, SM22 protein and myosin light chain
kinase [54]. The human cervical adenocarcinoma cell line HeLa
was purchased from the American Type Culture Collection
(Rockville, MA, USA). The human umbilical vein endothelial cells
(HUVEC) were purchased from Lonza (Walkersville, MD, USA)
and passaged 4–12 times. RVSMC and HeLa were maintained in
Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, Carls-
bad, CA) supplemented with 10% fetal bovine serum (FBS) and
100 U/ml penicillin and 100 mg/ml streptomycin. HUVEC were
cultured in complete endothelial cell growth medium-2 (EGM-2
BulletKit, CC3162, Lonza). All cell cultures were maintained in a
humidified atmosphere with 5% CO2/balance air at 37uC. To
establish quiescence, cells were incubated for 24 hr in the media in
which concentration of FBS was reduced to 0.2%. The possible
impact of Na
+,K
+-ATPase inhibition and Ca
2+-depletion on cell
viability and apoptosis was studied by lactate dehydrogenase
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48f Trim23//tripartite motif-containing 23 21.3760.05 21.2860.05 21.5760.08 21.6360.09 21.4060,09 21.3960,09
49t Snapc3//small nuclear RNA activating complex,
polypeptide 3
21.3660.05 21.4060.05 21.3560.05 21.4160.04 21.2460,07 21.3760,06
50t Gars//glycyl-tRNA synthetase 21.3160.02 21.3360.02 21.2460.02 21.2560.03 21.2560,03 21.3660,03
51o Cyp2r1//cytochrome P450, family 2, subfamily r,
polypeptide 1
21.3760.07 21.6360.08 21.3160.07 21.3460.07 21.3160,09 21.3660,06
52o Napb//N-ethylmaleimide-sensitive factor attachment
prote
21.3160.10 21.2760.11 21.3260.12 21.4360.10 21.3660,07 21.3560,10
53o Oraov1//oral cancer overexpressed 1 21.2960.04 21.4260.08 21.2760.09 21.3060.09 21.2260,08 21.3460,07
54o Piga//phosphatidylinositol glycan anchor biosynthesis,
class A
22.2760.07 22.9260.06 22.2960.04 22.5660.03 21.3360,06 21.3460,06
55f Dnajb5//DnaJ (Hsp40) homolog, subfamily B,
member 5
21.2460.04 21.2260.05 21.7660.06 21.7060.06 21.4660,09 21.3360,07
56f Siah2//seven in absentia 2 21.3460.02 21.2960.06 21.4760.09 21.5060.12 21.2760,10 21.3360,07
57t Ccdc101//coiled-coil domain containing 101 21.2260.06 21.3260.06 21.6360.10 21.5260.08 21.3060,04 21.3360,08
58t Ccdc76//coiled-coil domain containing 76 21.2360.05 21.5360.06 21.2660.05 21.2660.05 21.3560,06 21.3360,05
59d Rad17//RAD17 homolog (S. pombe) 21.2260.10 21.4260.05 21.3060.08 21.3260.07 21.2960,09 21.3260,07
60t Lrrfip1//leucine rich repeat (in FLII) interacting
protein 1
21.4960.08 21.5260.07 22.9260.16 23.6260.21 21.3060,09 21.3260,10
61t Zxdc//ZXD family zinc finger C 21.3160.06 21.2760.06 21.3960.11 21.3160.09 21.2760,11 21.2860,10
62t Zrsr2//zinc finger (CCCH type), RNA binding motif
and serine/a
21.4060.07 21.6860.09 21.3160.06 21.2460.07 21.2360,07 21.2860,07
63f Txndc11//thioredoxin domain containing 11 21.3160.05 21.3260.04 21.2660.02 21.3460.04 21.2260,03 21.2460,06
64o Ibtk//inhibitor of Bruton agammaglobulinemia
tyrosine kinase
21.3760.07 21.3860.06 21.4160.03 21.3760.04 21.2460,06 21.2360,07
65f Gopc//golgi associated PDZ and coiled-coil motif
containing
21.2160.07 21.2860.06 21.4060.05 21.3960.07 21.2460,06 21.2360,04
Genes whose expression was not affected by ouabain or K
+-free medium in the presence of Ca
2+ in at least one of cell types are shown in italics. Genes whose
expression was not affected by ouabain or K
+-free medium in the presence of Ca
2+ in all 3 types of cells shown in underlined italics. Gene functions are indicated in the
left column as: t – regulators of transcription/translation, RNA processing and degradation; d – regulators of cell adhesion, migration, proliferation, differentiation and
death; f - protein folding and ubiquitination; i – inflammation and immune response; o – other functional categories and genes withy unknown function.
doi:10.1371/journal.pone.0038032.t009
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chromatin cleavage, as described in details elsewhere [23,24,55].
Elevation of the [Na
+]i/[K
+]i ratio
Quiescent cells were washed with Ca
2+- and K
+-free DMEM
(Sp-DMEM; Invitrogen, Carlsbad, CA) and incubated for 3 hr in
either control medium containing 1.8 mM CaCl2 and 5 mM KCl
(Sp-DMEM+Ca,K) or in Ca
2+-free medium (Sp-DMEM+K)
containing 50 mM EGTA and 10 mM BAPTA-AM. To increase
the [Na
+]i/[K
+]i ratio, the Na
+,K
+-ATPase activity was inhibited
by the addition of ouabain or the omission of extracellular K
+ (K
+-
free medium, Sp-DMEM+Ca). Because the affinity of the
ubiquitous a1-Na
+,K
+-ATPase for ouabain and other cardiotonic
steroids (CTS) in rodents is ,1000-fold lower than in other
mammalian species [56], ouabain was added to the media with
human and rat cells at the concentrations of 3 and 3,000 mM,
respectively.
Intracellular content of exchangeable K
+ and Na
+
Intracellular content of exchangeable K
+ and Na
+ was
measured as the steady-state distribution of extra- and intracellular
86Rb and
22Na, respectively. To establish isotope equilibrium, cells
growing in 12-well plates were preincubated for 3 hr in control or
K
+-free medium (Sp-DMEM+Ca) containing 0.5 mCi/ml
86RbCl
or 3 mCi/ml
22NaCl and ouabain was added for the next 3 hr. To
test the action of K
+-free medium, cells were washed twice with
ice-cold Sp-DMEM+Ca. Then, cells loaded with
22Na were
transferred to Sp-DMEM+Ca, containing 3 mCi/ml
22NaCl,
whereas cells loaded with
86Rb were transferred to isotope-free
Sp-DMEM+Ca. After 3 hr, the cells were transferred onto ice,
washed 4 times with 2 ml of ice-cold medium W containing
100 mM MgCl2 and 10 mM HEPES-tris buffer (pH 7.4). The
washing medium was aspirated and cells were lysed with 1% SDS
and 4 mM EDTA solution. Radioactivity of incubation media and
cell lysates was quantified, and intracellular cation content was
calculated as A/am, where A was the radioactivity of the samples
(cpm), a was the specific radioactivity of
86Rb (K
+) and
22Na in the
medium (cpm/nmol), and m was protein content. For more details,
see [57].
Measurement of intracellular Ca
2+
Cells grown on glass cover slips were incubated for 30–40 min
in medium containing 5 mM fura 2-AM, washed twice and kept
for up to 30 min at room temperature before the experiments.
Then, the cover slips treated as indicated in figure and table
legends were mounted in a diagonal position in a 161 cm cuvette,
and fluorescence was determined under permanent stirring at
37uC( lex=340 and 380 nm, slit 4 nm; lem=510 nm, slit 12 nm),
using a SPEX FluoroMax spectrofluorimeter (Edison, NJ). Free
[Ca
2+]i was quantified as [Ca
2+]i=K d (R2Rmin)x(Rmax2R)
21,
where Kd is the dissociation constant of the Ca
2+-fura 2 complex
(224 nM at 37uC), and R=F340/F380 is the ratio of fluorescence at
lex=340 and 380 nm. To determine Fmax, the cells were treated
with 0.5 mM ionomycin in the presence of 1 mM CaCl2.T o
determine Fmin, MnCl2 was added at a final concentration of
2 mM.
Measurement if intracellular BAPTA
HeLa cells seeded in 12-well plates were incubated for 3 hr in
control or Ca
2+-free media containing 2 mCi/ml [
14C]-urea.
Then, the cells were washed with 463 ml of ice-cold medium W
and lysed for BAPTA measurement by addition of 200 ml of 10%
trichloroacetic acid containing 1 mM CaCl2 or for radioactivity
measurement as described above. The content of BAPTA in cell
Figure 12. Effect of Ca
2+-depletion on expression of ubiquitous Na
+
i,K
+
i-sensitive genes in HeLa, HUVEC and RVSMC. Cells were
incubated during 3 hrs in control medium containing 1.8 mM CaCl2 or in Ca
2+-containing K
+-free medium. To trigger Ca
2+-depletion, CaCl2 was
omitted and 50 mM EGTA and 10 mM BAPTA-AM were added. Increments of gene expression triggered by Na
+,K
+-ATPase inhibition in Ca
2+-containing
medium were taken as 100%. For absolute values of gene expression, see Tables 3 and 8.
doi:10.1371/journal.pone.0038032.g012
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triggered by addition of 10 mM EGTA (DA255). Intracellular
concentration of BAPTA (mmol/L) was calculated as DA255/
DA255StVi, where DA255St is the Ca
2+-dependent increment of A255
in the presence of 0.001 mmol BAPTA (internal standard) and Vi is
the volume of intracellular water (ml/mg protein). Vi was calculated
as the volume of [
14C]-urea available space Vi=V oAi/Aom, where
Ai and Ao are the radioactivity of [
14C]-urea in the cell lysate and
incubation medium, respectively (dpm), m is protein content in the
cell lysate (mg), and Vo is the volume of incubation medium (L)
used for Ao determination.
RNA isolation
Total RNA was extracted from cells grown in 6-well plates using
TRIzolH reagent (Invitrogen, Carlsbad, CA and purified with the
RNeasyH MinElute cleanup kit (Qiagen, Valencia, CA) following
the manufacturers’ protocols. Only the RNA samples that had
more than 7.0 RNA integrity number (RIN) and no detectable
genomic DNA contamination were used for the subsequent gene
array analyses. RNA quality was assessed by 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA). Microarray experiments
were performed with GeneChipH Human Gene 1.0 ST array
(which detects 28,869 gene products) and GeneChipH Rat Gene
1.0 ST array (detects 27 342 gene products). On both arrays, each
gene was represented by approximately 26 probes along the entire
length of the transcript (Affymetrix, Santa Clara, CA). 100 ng of
total RNA for each sample was processed with AmbionH WT
Expression Kit (Invitrogen). This kit uses a reverse transcription
priming method that specifically primes non-ribosomal RNA,
including both poly(A) and non-poly(A) mRNA, and generates
sense-strand cDNA as the final product. 5.5 mg of the single-
stranded cDNA was fragmented and labeled using the Affymetrix
GeneChipH WT Terminal Labeling Kit and 2.0 mg of the
resulting cDNA was hybridized on the chip.
GeneChip expression analysis
The whole hybridization procedure was conducted with the
Affymetrix GeneChipH system according to the protocol recom-
mended by the manufacturer. The hybridization results were
evaluated with Affymetrix GeneChipH Command Console Soft-
ware (AGCC). Quality of the chips was determined using
Affymetrix Expression Console. Data analysis was performed
within Partek Genomics Suite (Partek, St. Louis, Missouri). The
data were initially normalized by Robust Multichip Average
(RMA) algorithm, which uses background adjustment, quantile
normalization and summarization. Then, normalized data were
Figure 13. The signaling network possessing the highest score of 48 for association with differential expression of ubiquitous
Na
+
i,K
+
i-sensitive genes. The p-value and geometric fold change for each gene listed in Table 3 were overlaid onto a global molecular network
developed from information within the IPA Knowledge Base. Genes are represented as nodes of various shapes to represent the functional category
of gene product as shown in the top corner, and the biological relationship between two nodes is represented as a line. The up-regulated Na
+
i,K
+
i-
sensitive genes are shown in pink. Note that network’s Score of 48 is equal to -log(Fisher’s Exact test result). It means that there is a 1 in 10
48 chance
of getting a network from Ingenuity Knowledge Base containing at least the same number of eligible molecules by chance when randomly picking
molecules derived form 80 ubiquitous Na
+
i,K
+
i-sensitive genes listed in Table 3.
doi:10.1371/journal.pone.0038032.g013
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patterns in the dataset and high-light similarities and differences
among the samples. Major sources of variability identified within
the dataset by PCA were used as grouping variabilities for analysis
of variance (ANOVA) with n=4 for each group of samples. The
ensuing data were filtered to identify transcripts with statistically
significant variation of expression among the groups that are
modulated by at least 20%, with multiple testing correction by the
false discovery rate (FDR). The calculated p-value and geometric
fold change for each probe set identifier were imported into
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, http://www.
ingenuity.com) to ascertain networks, biological functions and
their pathophysiological implications. Functional information on
regulated gene was also obtained using PubMed and cited
publications.
Real-time quantitative RT-PCR
To validate data obtained by genome-wide Affymetric gene
arrays, we estimated changes in the gene expression for several
selected transcripts by qRT-PCR, which was performed using
Express SYBR GreenER qPCR Supermix kit (Invitrogen,
Carlsbad, CA, USA) according to the manufacture’s instructions.
The reaction was carried out with a 7900 HT Fast RT – PCR
system (Applied Biosystems, Foster City, CA, USA). Primers for
Egr1, Ptgs2 and Ppp1r15a were designed using Primer3Plus online
software from consensus sequences provided by Affymetrix for
Figure 14. Top significantly altered biological functions associated with differential expression of ubiquitous Na
+
i,K
+
i-sensitive
genes. The p-value and geometric fold change for each gene listed in Table 3 were imported into Ingenuity Pathway Analysis. The significance
criteria with a threshold of p=0.05 (or 1.3 when expressed as -log(p-value) is shown by line.
doi:10.1371/journal.pone.0038032.g014
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sens (59-TGACCGCAGAGTCTTTTCCT-39), Egr1-anti-sense
(59-AGCGGCCAGTATAGGTGATG-39), Ptgs2-sens (59-TGT
GTTGACATCCAGATCACAT-39), Prgs2-anti-sense (59-GCTG
CTTTTTACCTTTGACACC-39), Ppp1r15a-sens (59-GGCCA
TCTATGTACCTGGAGA-39) and Ppp1r15a-anti-sense (59 GA-
GAAGCGCACCTTTCTGG-39). All experiments were analyzed
in duplicate. b2 microglobulin mRNA expression was used to
normalize and compare the expression values of genes of interest.
The results were quantified by the DDCt method with Excel
Microsoft software.
Chemicals
Methyl-[
3H]-thymidine was purchased from ICN Biomedicals,
Inc. (Irvine, CA);
22NaCl and
86Rb were obtained from
PerkinElmer (Waltham, MA); [
14C]-urea was provided by
Amersham (Montreal, PQ). DEVD-AMC, DEVD-CHO and z-
VAD.fmk were procured from BIOMOL Research Laboratories
(Plymouth Meeting, PA). The remaining chemicals were supplied
by Gibco BRL (Gaithersburg, MO), Calbiochem (La Jolla, CA),
Sigma (St. Louis, MO) and Anachemia (Montreal, QC).
Figure 15. Mechanisms underlying transcriptomic alterations in normal and pathophysiological conditions: a working hypothesis.
Activation of Na
+-permeable channels such as NMDA receptors (1), Na
+/H
+ exchanger (2), voltage-gated K
+ channels (6) and inhibition of Na
+,K
+-
ATPase (4) lead to elevation of the [Na
+]i/[K
+]i ratio. In cells abundant with Na
+/Ca
2+ exchanger (3), the dissipation of transmembrane gradients of
monovalent cations is accompanied by elevation of [Ca
2+]i. Elevation of the [Na
+]i/[K
+]i ratio affects the expression of X1,2,3… and Z1,2,3… genes via
activation of unknown Na/K sensor(s) and Na/K response elements (Na/KRE). Expression of Z1,2,3… genes is also subjected to regulation by elevated
[Ca
2+]i via its interaction with calmodulin (CaM) and other Ca
2+
i sensors and diverse Ca
2+-response elements (CaRE), whereas Y1,2,3… genes lacking
Na/KRE are controlled by [Ca
2+]i only. The set of Na
+
i,K
+
i-sensitive transcription regulators shown as Xn, Yn and Zn contributes to overall
transcriptomic changes via activation of canonical response elements (RE) within V1,2,3… genes. Autocrine pathways triggered by the release of
interleukin 6 and other [Na
+]i/[K
+]i-sensitive regulators of gene expression (Zm) may also contribute to overall transcriptomic changes via activation of
their receptors (7).
doi:10.1371/journal.pone.0038032.g015
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